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1. SUMMARY 
_________________________________________________________________________ 
 
The advent of obstetric ultrasonography (US) has enhanced the early detection of various 
urinary tract anomalies. The widespread use of routine obstetric US has also substantially 
increased the number of patients detected with urinary tract anomalies. The objective of 
this research project was to clarify the long-term outcome of patients with antenatally 
detected urinary tract anomalies and to investigate whether the outcome of these patients 
differs from that of patients with postnatally detected conditions. 
 
The study population comprised 51 patients with vesicoureteral reflux (VUR), 48 with a 
multicystic dysplastic kidney (MDK), 46 with posterior urethral valves (PUV), and 68 with 
pelviureteric junction (PUJ) obstruction. In the studies of VUR, MDK, and PUV, 
anomalies were detected either antenatally (21 cases with VUR, 37 with MDK, 23 with 
PUV) by using obstetric US or postnatally during the neonatal period (cases with VUR) or 
during infancy. The one study of cases with PUJ obstruction included only patients whose 
conditions were detected antenatally. Of the total of 213 study patients, 209 were 
diagnosed and treated at the Hospital for Children and Adolescents, University of Helsinki, 
between 1983 and 1999, and 4 PUV patients at the Department of Pediatrics, Tampere 
University Hospital, between 1983 and 1997. The long-term outcome of all patients was 
retrospectively analyzed, and in cases with VUR and PUV, the outcome of antenatally 
detected patients was compared with that of postnatally detected symptomatic patients. 
Furthermore, patients with PUV were invited to outpatient visits to determine the current 
status of their urinary tract and kidney function; 17 patients agreed to participate and were 
prospectively studied.  
 
In cases with fetal VUR, significantly more bilateral dilating VUR was found in neonatally 
than in antenatally diagnosed patients (53% vs. 29%, p=0.05). Fourteen percent of patients 
presented with congenital renal dysplasia. Focal scars developed during follow-up in 19% 
of renal units, explicitly in dilating VUR and only in neonatally detected cases (p<0.005). 
For MDK, ultrasonographic follow-up showed involution in 13 cases (27%), whereas in 35 
cases (73%) the renal conglomerate persisted throughout the study period; 32 of these 
patients eventually underwent nephrectomy. In involuted cases, the size of the affected 
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mass was significantly smaller throughout the study period than in those undergoing 
nephrectomy. The difference between the two groups increased continuously during 
follow-up, the mean involution rate being 2.5 cm/year versus 0.6 cm/year up to 18 months 
(p<0.0001). In cases with PUV, the renal outcome was poor (GFR < 60ml/min/1.73m2) in 
14 patients (30%). The poor outcome was associated with a significantly higher nadir 
serum creatinine value during the first year of life (p<0.001), with bilateral VUR 
(p<0.005), and with breakthrough urinary tract infections (UTIs) (p<0.05). The long-term 
outcome of antenatally detected cases did not differ from that of postnatally detected cases 
(p=0.25). Among the conservatively treated cases with unilateral PUJ obstruction, none of 
the patients’ good renal function deteriorated during follow-up. In the early-operated 
group, primary good function remained unchanged in all. In some cases, moderate renal 
function improved after early pyeloplasty, whereas in cases with poor function no 
improvement occurred. In cases who underwent late pyeloplasty, primary good function 
remained unchanged. In all except one patient with bilateral obstruction treated 
conservatively, both the grade of hydronephrosis and split renal function remained 
unchanged.  
 
In conclusion, several demographic features of fetal VUR differ from each other, 
depending on whether VUR is detected antenatally or postnatally. Renal damage may be of 
congenital origin or it may be acquired secondarily to UTI. The risk of acquired renal 
scarring is particularly high if dilating VUR is not detected until neonatally after the first 
UTI. Of patients with MDK, involution occurs in approximately one-fourth, usually within 
14 months. When surgery is to be performed, the age of 2 years is recommended. In 
patients with PUV, poor long-term outcome is associated with bilateral VUR and with 
breakthrough UTIs. The nadir serum creatinine value during the first year of life is a 
valuable parameter for assessing the long-term outcome. The outcome of patients with 
antenatally detected PUV does not differ from that of patients with a postnatally detected 
condition. Unilateral PUJ obstruction is mostly a benign condition with good outcome. 
Pyeloplasty may be indicated in selected cases. A portion of the cases with bilateral PUJ 
obstruction can be followed conservatively. 
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3. ABBREVIATIONS 
_________________________________________________________________________ 
 
51Cr-EDTA 51chromium-ethylenediamine tetra-acetic acid 
CRF chronic renal failure 
CRP C-reactive protein 
DMSA renal scanning using 99mtechnetium-dimercaptosuccinic acid 
DTPA renal scanning using 99mtechnetium-diethylenetriamine penta-acetic acid 
ESRD end-stage renal disease 
GFR glomerular filtration rate 
IVU intravenous urography 
MAG-3 mercaptoacetyl triglycine 
MDK multicystic dysplastic kidney 
PN pyelonephritis 
PUJ pelviureteric junction 
PUV posterior urethral valves 
US ultrasonography 
UTI urinary tract infection 
UVJ ureterovesical junction 
VCUG voiding cystourethrography 
VUR vesicoureteral reflux 
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4. INTRODUCTION 
_________________________________________________________________________ 
 
Antenatally performed ultrasonography (US) has dramatically changed the approach to 
congenital anomalies, particularly those involving the genitourinary tract. The first report 
of antenatal detection of a fetal urologic anomaly dates back to 1970 (Garrett et al. 1970). 
Since then, ultrasonographic evaluation of the fetus has developed considerably, and the 
number of fetuses identified with known or suspected urinary tract anomalies has increased 
markedly. Reported incidences of antenatally detected congenital anomalies affecting the 
genitourinary system have varied from 0.25% to 1.43% of live births (Helin and Persson 
1986, Livera et al. 1989, Rosendahl 1990, Gunn et al. 1995, James et al. 1998). The most 
common finding is hydronephrosis, which accounts for up to 50% of all abnormalities 
detected during the antenatal period (Saari-Kemppainen et al. 1990, Blyth et al. 1993, 
Lama et al. 1996).  
 
Most patients with an antenatally detected urinary tract anomaly can be managed 
conservatively pre- and postnatally. In some cases, intrauterine intervention has been 
attempted, but the results have not been promising. Conservatively treated patients need 
regular follow-up, and antimicrobial prophylaxis is often indicated. In cases where renal 
function is poor or is at risk of declining, surgical treatment is warranted. In a few patients, 
the kidneys may deteriorate despite attempts at salvage. These patients eventually require 
kidney transplantation.  
 
The greatest advantage of antenatal detection is that the examinations and treatment 
needed can be offered immediately after birth, before possible permanent damage due to 
e.g. urinary tract infection develops. On the other hand, the widespread use of routine 
antenatal US has significantly altered the detection and mode of presentation of many 
urological anomalies. Consequently, pediatrics and pediatric urologists are now confronted 
with a large number of infants with asymptomatic urinary tract malformation. Finding, for 
instance, hydronephrosis in the fetus may encourage treatment of an abnormal-appearing 
kidney that might otherwise remain asymptomatic for a lifetime. Furthermore, the relative 
frequency with which hydronephrosis is found can lead to considerable parental anxiety 
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and utilization of medical resources. Hence, the frequent finding of fetal hydronephrosis 
presents both an opportunity and a dilemma.  
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5. REVIEW OF THE LITERATURE 
_________________________________________________________________________ 
5.1. ANTENATAL ULTRASOUND 
 
The first report on the use of US in pregnancy was published in 1958 (Donald et al. 1958). 
Ultrasonographic evaluation of the fetus has since developed considerably. During the last 
few decades the use of fetal US has increased dramatically, and several countries have 
instituted programs for routine antenatal screening. With the aid of antenatal US, 
gestational age can be determined, multiple pregnancies detected, fetal growth followed, 
and perhaps most importantly, congenital malformations identified. US has become an 
essential component of fetal evaluation, allowing antenatal counselling, prompt transfer to 
units specializing in newborn care, and appropriate treatment after birth. 
 
Congenital malformations occur in 2% to 3% of all infants (Ash et al. 1977, Reddy and 
Mandell 1998). With antenatal US, congenital malformation is detected in 0.5% to 2.4% of 
fetuses (Jassani et al. 1982, Helin and Persson 1986, Rosendahl and Kivinen 1989, Chitty 
et al. 1991, Levi et al. 1995). Reported sensitivities of antenatal US in detecting congenital 
anomalies range from 8.7% to 83.0% (Campbell and Pearce 1983, Rosendahl and Kivinen 
1989, Chitty et al. 1991, Saari-Kemppainen et al. 1994, Skupski et al. 1996). The wide 
range in reported sensitivity is mostly due to some of the screening studies being 
conducted among the general population (Rosendahl and Kivinen 1989, Saari-Kemppainen 
et al. 1990, Chitty et al. 1991, Skupski et al. 1996, Grandjean et al. 1999) and others in 
high-risk populations (Campbell and Pierce 1983, Sabbagha et al. 1985). Different 
classifications and exclusion criteria of anomalies also influence the results. The frequency 
of US performed during pregnancy, the time of gestation when US is performed, and the 
skill and technique of the ultrasonographer may also vary, causing discrepancy in results. 
Specificity of antenatal US has been reported to be almost 100% (Rosendahl and Kivinen 
1989, Chitty et al. 1991, Goncalves et al. 1994, Carrera et al. 1995). 
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5.2. ANTENATAL DETECTION OF FETAL UROLOGICAL ANOMALIES 
 
At present, many of the urinary tract anomalies are detected in utero. The incidence of 
antenatally detected urinary tract anomalies has been reported to lie between 0.25% and 
1.43% (Helin and Persson 1986, Livera et al. 1989, Rosendahl 1990, Gunn et al. 1995, 
James et al. 1998). Patients with urinary tract anomalies frequently also have other 
anomalies (Cendron et al. 1996). 
 
In antenatal US examination, fetal kidneys and bladder can be visualized as early as in 10 
to 12 weeks of gestation, and most kidneys are identified by the 18th week (Saphier et al. 
2000). Although some urinary tract anomalies may be identified in the 12th to 14th week of 
gestation, an accurate assessment cannot be made until after the 16th to 18th week of 
gestation because before this it is impossible to distinguish the cortex, medulla, and central 
echo in the renal sinus representing the pelvis (Elder and Duckett 1988, Bronshtein et al. 
1990). Many of the anomalies today are detected before the 20th week of gestation; 
however, the detection rate increases with fetal age (Kullendorff et al. 1984, Helin and 
Persson 1986, Rosendahl and Kivinen 1989, Economou et al. 1994). In the US 
examination, a normal renal collecting system (calyces and pelvis) should not be seen, and 
a visible renal pelvis is indicative of hydronephrosis (Centron et al. 1996). Diagnostic 
criteria for significant fetal hydronephrosis have, however, remained controversial. Normal 
fetal ureters and urethra are not generally seen. Cystic lesions are easily identified on US 
examination, but could be confused with dilated renal calyces. Dilated calyces (caliectasis) 
has been found to correlate well with functionally significant obstruction (Coplen 1997). 
Cortical cysts and echogenic parenchyma suggest that dysplasia and severe renal damage 
may be present (Coplen 1997). Renal function of the fetus can also be estimated by the 
amount of amniotic fluid detected by US. Oligohydramnios is an accurate reflection of 
decreased urinary output and the most important measure of renal impairment. A normal 
amniotic fluid volume indicates that at least one renal unit is functioning (Lama et al. 
1996).  
 
The most common antenatally detected urinary tract anomalies are pelviureteric junction 
(PUJ) obstruction, multicystic dysplastic kidney (MDK), renal duplication, posterior 
urethral valves (PUV), obstructed or nonobstructed megaureter, vesicoureteral reflux 
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(VUR), transitional urinary tract dilatation, and renal agenesis. Other urinary tract 
anomalies include ectopic ureter, ureterocele, Prune Belly syndrome, extrarenal pelvis, 
megacystis-megaureter syndrome, urethral aplasia, polycystic kidney disease, and a simple 
renal cyst. In antenatal differential diagnostics, megacalicosis, ovarian cyst, hydrocolpos, 
sacrococcygeal teratoma, bowel duplication, duodenal atresia, and anterior meningocele 
should also be taken into consideration as a possible, albeit rare, causes of hydronephrosis 
(Lama et al. 1996, Elder 1997). 
 
In the past, children with urinary tract anomalies were identified either during physical 
examination carried out because of a palpable mass or when a complication, such as 
infection, bleeding, or the development of kidney stones, occurred. Approximately 80% of 
neonates with an antenatal diagnosis of urinary tract abnormality have no signs or 
symptoms at birth (Thomas and Gordon 1989). Thus, antenatal US enhances the detection 
of potentially significant urinary tract anomalies before postnatal onset of symptomatic 
disease, which allows diagnostic evaluation and appropriate treatment to be given before 
complications occur.  
 
 
5.3. ANTENATAL DETECTION OF HYDRONEPHROSIS 
 
Hydronephrosis is recognized in US examination as a dilatation of the renal pelvis, usually 
associated with dilatation of the calyces. Hydronephrosis can be unilateral or bilateral. The 
ureters and bladder may also be dilated. The incidence of hydronephrosis detected by 
antenatal US has been reported to be 1 per 100 pregnancies, but only 1 in 500 represents a 
significant urological problem (Thomas 1990). The incidence of hydronephrosis varies 
according to the study depending upon the criteria applied and the timing of US. The 
degree of hydronephrosis varies based on the stage of pregnancy and the underlying 
etiology. Measurement of the anteroposterior diameter of the intrarenal pelvis in a 
transverse plane is the simplest and most commonly used technique for ultrasonographic 
diagnosis of hydronephrosis. There is, however, no consensus on the measurements for a 
normal renal pelvis. A renal pelvic anteroposterior diameter of 10 mm was earlier 
considered the cut-off between normal and abnormal (Grignon et al. 1986, Cendron et al. 
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1996). However, primary VUR was often missed using a cut-off point this high. It has 
subsequently been proposed that infants with a renal pelvic anteroposterior diameter over 4 
or 5 mm in antenatal US should be investigated postnatally (Jaswon et al. 1999, Saphier et 
al. 2000).  
 
In many cases, antenatally detected hydronephrosis will resolve either before birth or 
during the first year of life, but in some cases the hydronephrosis grade remains stable or 
even increases. In the majority of patients, renal function will develop normally after birth 
despite the possible persistence of hydronephrosis. Surgical intervention is, however, 
sometimes necessary to avoid deterioration of renal function. 
 
 
5.4. ANTENATAL INTERVENTION FOR URINARY TRACT ANOMALIES 
 
Intrauterine surgery was introduced with optimism. Reports concerning fetal surgery have 
not, however, been promising. The two basic objectives of intrauterine intervention in a 
fetus with a urinary tract anomaly are 1) to restore sufficient amniotic fluid to allow normal 
pulmonary development, and 2) to prevent renal dysplasia. Nevertheless, experimental and 
clinical evidence indicate that both renal dysplasia and pulmonary hypoplasia may be 
irreversible by the time the urinary tract dilatation is first noted by antenatal US (Coplen 
1997). 
 
Prenatal intervention is mainly limited to male fetuses with early obstruction due to PUV. 
In the early 1980s, open fetal surgery was performed in some cases with obstructive 
uropathy, but the results were quite poor. Vesicoamniotic shunt placement has also been 
used since the early 1980s, with Golbus et al. describing the first case in 1982. 
Complications occur in nearly half of all patients, the overall survival ranging from 22% to 
62% (Manning et al. 1986, Elder et al. 1987, Coplen 1997, Freedman et al. 1999, Holmes 
et al. 2001).  
 
In some recent studies, percutaneous fetal cystoscopy has been used in fetal intervention 
with good results. This technique allows direct visualization and evaluation of the course 
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of obstruction, and in cases with PUV, mechanical or laser ablation can be performed 
(Quintero et al. 1995, 2000).  
 
 
5.5. PELVIURETERIC JUNCTION (PUJ) OBSTRUCTION  
 
Pelviureteric junction obstruction is the most common cause of antenatal and neonatal 
hydronephrosis. With the use of routine obstetric US, hydronephrosis suspected of being 
caused by PUJ obstruction is observed in approximately 1 in 1000 live births (Cendron et 
al. 1996). The obstruction in the junction between the pelvis and the ureter can be caused 
by a variety of either intrinsic or extrinsic anatomical or functional abnormalities that 
restrict urinary flow. Intrinsic obstruction may be due to focal narrowing at the junction 
between the pelvis and the ureter or by segmental areas of abnormal peristalsis (Koff 
1999). Extrinsic obstruction may be caused by kinks, angulations, or aberrant vessels. 
Obstruction is usually partial, and the condition may vary in its severity. Renal function on 
the affected side can be either normal or reduced (Koff and Wise 1996).  
 
Obstruction has been proposed to be defined as ”any restriction to urinary outflow which if 
untreated will injure the kidney” (Koff 1987). Peters (1995) suggested that obstruction be 
defined as any restriction in urinary drainage that impairs the functional potential of the 
kidney. In the newborn, however, it is difficult to assess the significance of an obstruction 
to urinary flow because the newborn kidney displays anatomic and functional immaturity. 
At birth, there is a significant depression in renal function. Thereafter, renal function 
improves quickly as the kidney grows and as changes occur in renal vascular resistance 
and renal perfusion (Koff 1998). Consequently, hydronephrosis in the newborn has the 
potential for spontaneous improvement or resolution with maturation, if no significant 
obstruction is present.  
 
Earlier, infants with PUJ obstruction were detected because of an abdominal mass, 
whereas pain, hematuria, or UTI was commonly seen in older children (Koff and Wise 
1996). At present, 30% to 50% of patients are discovered in utero as a result of antenatal 
US screening (Cendron et al. 1996). PUJ obstruction usually occurs unilaterally. In 10% to 
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40% of patients, the disease has been reported to be bilateral (Koff and Wise 1996, Reddy 
and Mandell 1998). In unilateral cases, the left kidney is 1.5-3 times more likely to be 
affected. Males predominate, the M/F ratio being 1.8-2.8:1 (Cartwright et al. 1992, Salem 
et al. 1995, Cendron et al. 1996, McAleer and Kaplan 1999, Subramaniam et al. 1999). 
Although the occurrence of PUJ obstruction is mostly sporadic, familial tendency has been 
observed (Atwell 1985). Coexisting abnormalities, especially genitourinary, do occur, the 
prevalence of e.g. VUR being 15% (Cendron et al. 1996). Voiding cystourethrography 
(VCUG) is recommended in cases with PUJ obstruction. The association between MDK 
and contralateral PUJ obstruction is well-known, with the dysplastic kidney possibly 
reflecting the extreme end of the clinical spectrum of PUJ obstruction (Reddy and Mandell 
1998).  
 
In US examination, PUJ obstruction can be suspected when hydronephrosis is present 
without a dilated ureter and bladder. The degree of renal pelvic and calyceal dilatation and 
thickness of the renal cortex may vary. The initial postnatal US performed within the first 
few days of life may appear normal despite significant obstruction due to oliguria. When 
hydronephrosis has been detected antenatally, renal US examination should be repeated 
(Cendron et al. 1996). In many cases, PUJ obstruction may result in clinically apparent but 
functionally insignificant dilatation of the upper urinary tract. Although ultrasonographic 
examination is the cornerstone of screening for PUJ obstruction, the degree of 
hydronephrosis has not proved to be a good indicator for the presence of obstruction. 
Currently, no single test can reliably predict whether a hydronephrotic kidney will 
deteriorate or improve. Excretory urography (IVU) has traditionally been the method used 
to evaluate hydronephrosis, but it has significant limitations in neonates. Renal isotope 
scan with either 99mtechnetium-diethylenetriamine penta-acetic acid (DTPA) or 
mercaptoacetyl triglycine (MAG-3) is now most widely used to assess the presence or 
absence of obstruction. In a renal isotope scan, split renal isotope uptake and isotope 
washout pattern and half time can be measured. Each of these parameters has its own 
limitations and is unable to accurately assess whether significant obstruction is present. 
The washout curve is subject to many variables in the newborn, including transitional low 
glomerular filtration rate (GFR). The deterioration in split renal isotope uptake during 
follow-up has been suggested to be the only reliable proof of the presence of obstruction 
(Koff 1998, Ulman et al. 2000). Magnetic resonance urography, which combines anatomic 
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and functional information, has recently been found to be a promising imaging modality in 
assessing patients with hydronephrosis; reports concerning its clinical use are still, 
however, quite limited (Leppert et al. 2002, Perez-Brayfield et al. 2003). 
 
When surgery is considered necessary, a PUJ obstruction is corrected by performing a 
pyeloplasty, in which the pelviureteric junction is excised and the ureter and renal pelvis 
are reattached. A dismembered Anderson-Hynes pyeloplasty is usually performed. Much 
controversy, however, exists about the indications and optimal timing of surgical 
treatment. Some surgeons advocate early pyeloplasty to optimize renal development and 
function by preventing long-term exposure to obstruction (King et al. 1984, DiSandro and 
Kogan 1998, Palmer et al. 1998, Zupancic et al. 2002). Others favor observation and late 
pyeloplasty only if renal function decreases in the affected side or the patient becomes 
symptomatic (Ransley et al. 1990, Blyth et al. 1993, MacNeily et al. 1993, Koff and 
Campbell 1994).  
 
The outcome of patients with PUJ obstruction is often good because function of the 
contralateral kidney is usually normal. In most cases of antenatally detected unilateral PUJ 
obstruction, the outcome of the affected side is favorable as well; hydronephrosis does not 
progress, renal function does not deteriorate, and subsequent surgery is not required (Koff 
1998). Patients with bilateral PUJ obstruction are naturally at greater risk for poor outcome 
(Saphier et al. 2000).  
 
 
5.6. MULTICYSTIC DYSPLASTIC KIDNEY (MDK) 
 
Multicystic dysplastic kidney is a congenital anomaly and is the second most common 
cause of abdominal mass in the newborn (Cendron et al. 1996). The first description of 
MDK found at autopsy is by Cruveilhier in 1836 (Bloom and Brosman 1978). A hundred 
years later, Schwartz identified and removed MDK during a surgical exploration (Robson 
et al. 1995). In 1955, Spence suggested that MDK be considered an entity apart from 
polycystic kidney disease and other cystic disorders.  
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While the etiology of MDK is unconfirmed, it is thought that either early obstruction of the 
ureteric bud leads to dysplasia or dysplasia is a primary condition associated with ureteric 
bud and nephrogenic blastomal abnormalities (Beck 1971). In MDK, the renal parenchyma 
is replaced by nonfunctioning, noncommunicating cysts of variable size. The normal 
pelveocalyceal system is absent, and the proximal ureter is atretic or nonpatent (Gordon et 
al. 1988).  
 
MDK usually develops in a population sporadically. It has, however, been reported as a 
feature of some inherited syndromes and chromosomal disorders and also to manifest in 
siblings (Zerres et al. 1984, Moazin et al. 1997). Furthermore, a recent report documents 
an inheritance pattern in three affected families (Belk et al. 2002). Exposure to teratogens 
has also been claimed to be a cause of MDK in some cases (Robson et al. 1995). The risk 
of MDK among babies of both pregestational and gestational diabetic mothers is increased 
(Ylinen and Wikström 2002). 
 
MDK is usually unilateral, the left side more frequently being affected (Robson et al. 
1995). However, MDK may be bilateral, which usually results in stillbirth or death within 
the first few hours of life due to accompanying pulmonary hypoplasia (Dungan et al. 1990, 
Robson et al. 1995). The incidence of unilateral MDK has been estimated to be 1 in 4100-
4300 live births, and the combined incidence of unilateral and bilateral MDK 1 in 3600 
births (Gordon et al. 1988, Ylinen and Wikström 2002). Males are slightly more often 
afflicted than females (Robson et al. 1995). 
 
Unilateral MDK is commonly associated with malformations of both the upper and the 
lower urinary tract. Anomalies of the contralateral kidney are present in 22% to 53% of 
patients with MDK (Greene et al. 1971, Sapin et al. 1994, Kessler et al. 1998, Perez et al. 
1998). The most frequently associated anomaly is VUR, which occurs in 9% to 43% of 
patients (Wacksman and Phipps 1993, Karmazyn and Zerin 1997, John et al. 1998, Kessler 
et al. 1998, Perez et al. 1998). 
 
Until recently, MDK was typically discovered in a postnatally performed physical 
examination. However, most MDKs are not palpable at birth (Cendron et al. 1996). Today, 
MDK is usually detected antenatally during routine obstetric US examination. US has been 
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shown to be advantageous in the diagnosis and follow-up of MDK and also in detecting 
any associated anomalies. Renal isotope scan (DMSA, DTPA, or MAG-3) is the preferred 
instrument to prove the absence of function of MDK, thus confirming the diagnosis. A 
VCUG study is recommended to be performed on all patients with MDK because of the 
increased incidence of associated VUR (Cendron et al. 1996). 
 
The management of MDK is still controversial. Earlier, the routine treatment was 
nephrectomy, which established the final diagnosis. At present, conservative management 
is favored because the natural history of MDK is now better known and recent reports have 
shown that a significant number of kidneys with MDK will undergo spontaneous 
involution (Wacksman and Phipps 1993, Oliveira et al. 2001). There is, however, 
considerable variation in the reported involution rates of MDK, ranging from 10% to 75% 
(Vinocur et al. 1988, Orejas et al. 1992, Strife et al. 1993, Wacksman and Phipps 1993, 
Sukthankar and Watson 2000, Oliveira et al. 2001).  
 
Patients with unilateral MDK are usually asymptomatic. Such complications as 
malignancy, hypertension, pain, and UTI have been related to MDK. A review of the 
literature identified some 18 cases of malignancy associated with MDK, including 11 cases 
of Wilms’ tumor in pediatric patients, with the remainder mostly displaying adult-type 
renal adenocarcinoma (Perez et al. 1998, Mingin et al. 2000). The risk of Wilms’ tumor 
arising in MDK has been estimated to be 3- to 10-fold that of the general pediatric 
population (Perez et al. 1998, Beckwith 1992). Nineteen cases of hypertension have been 
associated with MDK (Husmann 1998, Snodgrass 2000). In only 7 of the 18 cases 
subjected to nephrectomy, however, did hypertension become resolved. Ambrose et al. 
(1982) described several adult patients who had experienced pain and urinary infection. 
However, in other studies, the reported frequencies of UTIs have been similar to those of 
children without MDK (Feldenberg and Siegel 2000, Oliveira et al. 2001) 
 
The outcome of patients with unilateral MDK as the only malformation is generally 
expected to be good. Because the ipsilateral kidney is nonfunctioning, the prognosis 
depends on the contralateral kidney. In patients with unilateral MDK, the contralateral 
kidney usually grows compensatorily to take care of renal function. Compensatory renal 
growth has been suggested to start in utero and continue after birth, the largest increase in 
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length occurring during the first six months (Glazebrook et al. 1993, Mandell et al. 1993, 
John et al. 1998). In many studies, renal function has been reported to be normal in 
patients with unilateral MDK, but in some studies serum creatinine has been noted to be 
slightly elevated in patients with MDK (Orejas et al. 1992, Heymans et al. 1998, Rudnik-
Schöneborn et al. 1998, Kuwertz-Broeking et al. 2004). The outcome of patients with 
MDK associated with other significant urinary tract anomalies is less promising 
(Feldenberg and Siegel 2000).  
 
 
5.7. VESICOURETERAL REFLUX (VUR) 
 
Vesicoureteral reflux is an abnormal condition, in which urine flows in a retrograde 
direction from the bladder into the upper urinary tract. Normally, the ureters enter the 
bladder at an oblique angle, and the intramural section of the ureter acts as a flap-valve 
mechanism as the bladder fills, preventing urine from backing up and returning into the 
ureters. The valve-like action creates an important barrier that keeps the kidney free of 
bacteria and prevents the high pressure of a filled or micturating bladder to affect the ureter 
and the kidney (Rushton 1999). Anatomic or functional abnormality of the normally 
competent ureterovesical junction can lead to VUR (Decter 2001). VUR can be primary or 
secondary. Primary VUR is congenital and is not associated with any underlying 
neuromuscular or obstructive phenomenon. Primary VUR is assumed to be due to an early 
malformation in the ureteric bud, which can lead to the development of a shorter 
intramural section of the ureter, compromising its ability to act as a flap valve (Mackie et 
al. 1975, Belman 1997). Secondary VUR occurs in the presence of a bladder outlet 
obstruction or abnormal bladder function, including neurogenic bladder. VUR can also be 
transient, occurring in a normal urinary tract during and immediately after acute UTI 
(Jones and Asscher 1992).  
 
Primary VUR is the most common congenital anomaly of the urinary tract. The true 
prevalence of VUR in healthy infants and children is unknown, but it has been estimated to 
be less than 1% (Jacobson et al. 1999). VUR is usually diagnosed in connection with UTI. 
Consequently, most studies concerning the frequency of VUR are performed on patients 
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suffering from UTI, VUR being found in 25% to 40% of these patients (Blickman et al. 
1985, Jodal 1987, Merrick et al. 1995). With the advent of routine obstetric US, some of 
the patients are now detected antenatally. In 4% to 28% of cases, antenatally detected 
hydronephrosis has been reported to be due to VUR (Najmaldin et al. 1990, Ring et al. 
1993, Gunn et al. 1995, Anderson et al. 1997, MacIlroy et al. 2000, Brophy et al. 2002). 
VUR diagnosed in the evaluation of antenatally detected hydronephrosis is often of high 
grade and occurs more frequently in boys than in girls (Gordon et al. 1990, Boachrine et al. 
1996). Clinically presenting VUR, by contrast, is more common in girls (Winberg et al. 
1974, Blickman et al. 1985, Bisset 1987, Jodal 1987, Skoog et al. 1987). In antenatally 
detected patients, especially in male infants, VUR is primarily thought to be anatomic in 
origin, whereas in older girls voiding dysfunction and detrusor instability are well 
recognized as assisting factors in the etiology of VUR (Gordon et al. 1990, Snodgrass 
1991, Sillen 1999). However, some studies suggest that bladder dysfunction and high 
intravesical pressure may have a contributory role in male infants with high bilateral VUR 
(Sillen et al. 1992, Capitanucci et al. 2000).  
 
The etiology of VUR involves a substantial genetic component, supported by the 
observation that VUR is frequently found in multiple members of the same family (Scott et 
al. 1997, Devriendt et al. 1998, Mak and Kuo 2003). The likelihood that the sibling of a 
child with VUR will prove to have reflux is 27% to 42% (Noe 1992, Kenda and Zupancic 
1994, Wan et al. 1996). The risk of VUR in offspring of parents with reflux is also 
increased compared with the general population (Noe et al. 1992). 
 
VUR can be diagnosed most accurately by conventional radiopaque VCUG, where the 
severity of VUR can be graded according to the appearance of the ureters and calyces. The 
severity of VUR is dependent on the length of the submucous tunnel, the diameter and 
location of the ureteral opening, and the voiding pressure within the bladder (Anand et al. 
1991). The use of several different classifications in the past has led to confusion. At 
present, the most widely accepted grading system is that of the International Classification, 
which grades VUR from I to V (Lebowitz et al. 1985). In VUR follow-up, isotope VCUG 
is also useful (Fretzayas et al. 1984, Polito et al. 2000b). Furthermore, contrast-enhanced 
voiding urosonography has recently been found to be have promise in the follow-up of 
VUR (Darge et al. 2002, Uhl et al. 2003). 
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In 1960, Hodson and Edwards first demonstrated the association between VUR and renal 
scarring. VUR alone does not impact renal function. Refluxing urine can, however, 
transport bacteria from the lower urinary tract towards the kidneys, thus predisposing the 
patients to pyelonephritis (PN) and renal damage. Hodson et al. (1975) found that VUR 
and PN alone does not cause renal damage, but intrarenal reflux in combination with 
bacilluria permits invasion of the renal parenchyma by bacteria, which was also confirmed 
by Ransley and Risdon (1978). Intrarenal reflux refers to retrograde passage of urine from 
the renal pelvis into the collecting tubules. Today, VUR is widely recognized to be a 
significant risk factor for both the development of recurrent PNs and progressive renal 
scarring (reflux nephropathy) (Jodal 1987, Anand et al. 1991, Smellie et al. 1992, 
Wennerström et al. 2000, Nuutinen and Uhari 2001, Sweeney et al. 2001). Up to 50% of 
patients with PN and VUR have been reported to show evidence of renal parenchymal 
scarring (Jodal 1987, Anand et al. 1991, Smellie et al. 1992, Sweeney et al. 2001). The 
extent of scarring is proportional to the severity of VUR (Winter et al. 1983, Smellie et al. 
1985, Jodal 1987, Weiss et al. 1992, Stokland et al. 1996), and the frequency of scarring is 
related to the number of recurrent episodes of breakthrough UTIs (Jodal 1987). In addition, 
in several reports, the risk of renal scarring has varied according to the patient’s age, with 
infants under 1 year being at the highest risk and those older than 5 years at the lowest 
(Gleeson and Gordon 1991, Martinell et al. 1995). However, in the study of Benador et al. 
(1997), the development of renal scars was found to be independent of children’s age.  
 
Fetal VUR diagnosed in conjunction with the antenatal detection of hydronephrosis in US 
examination is associated with congenital renal damage. Renal scarring has been reported 
to occur in up to 40% of patients with antenatally detected VUR before developing any 
UTI (Ring et al. 1993, Marra et al. 1994, Assael et al. 1998, Sweeney et al. 2001). The 
cause of congenital renal damage remains uncertain. It has, however, been speculated 
whether VUR operating in utero interferes with metanephric differentiation or whether 
congenital renal dysplasia and VUR are separate expressions of a malformed urinary tract, 
frequently coexisting, but not necessarily causally related (Risdon et al. 1993).  
 
Most VUR are known to resolve spontaneously during childhood due to ”maturation” of 
the vesicoureteral valve. Controversy exists, however, about indications and optimal 
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timing of surgery. The most commonly used treatment modes are conservative follow-up 
by using low-dose antimicrobial prophylaxis, surgical endoscopic treatment, and ureteral 
reimplantation. The surgical correction of VUR eliminates the possibility of infected urine 
reaching the renal parenchyma, while medical treatment with chemoprophylaxis aims to 
prevent urine from becoming infected. Conservative management is currently favored as 
the primary mode of treatment because spontaneous cessation rates of severe VUR have 
been found to reach 40% to 60% in many studies, with resolution of lower grades of VUR 
being even better (Ring et al. 1993, Huang and Tsai 1995, Assael et al. 1998, Herndon et 
al. 1999, Farhat et al. 2000). A well-known alternative to long-term antimicrobial 
prophylaxis and open surgery is an endoscopic subureteric injection of tissue-augmenting 
substances. Dextranomer/hyaluronic acid copolymer, polytetrafluoroethylene paste, and 
collagen are described to successfully eliminate VUR in 60-90% of patients (Puri et al. 
1995, Reunanen 1995, Kumon et al. 1997, Läckgren et al. 1999, Puri et al. 2003). In many 
centers, ureteral reimplantation is undertaken only in patients with severe VUR or in those 
with recurrent UTIs, poor compliance, or renal scarring. By contrast, Yu et al. (1997) 
advocated early antireflux surgery since they observed that renal units with reflux 
nephropathy are susceptible to UTI and new scar formation. However, in studies, including 
the International Reflux Study, where the frequency of renal scars in surgically versus 
medically treated patients has been compared, no difference has been observed 
(Anonymous 1987a, Smellie et al. 1992, Piepsz 1998, Smellie et al. 2001, Wheeler et al. 
2003). 
 
Impairment of growth and scarring of exposed kidneys are the main types of 
morphological damage associated with VUR. Reflux nephropathy can result in end-stage 
renal disease (ESRD), hypertension, or both. In approximately 10% to 15% of cases, 
ESRD is caused by reflux nephropathy (Bailey et al. 1994, Craig et al. 2000). The 
incidence of renal insufficiency in patients with reflux nephropathy is approximately 10% 
to 14% (Jacobson et al. 1989, Zhang and Bailey 1995, Martinell et al. 1996). The risk of 
hypertension in patients with renal scarring varies based on the length of follow-up and the 
severity of scarring. In follow-up studies of children with renal scarring, 6% to 13% of 
children with scarring will develop hypertension (Goonasekera et al. 1996, Martinell et al. 
1996). In adults, hypertension has been reported to develop in up to 38% of patients with 
reflux nephropathy (Zhang and Bailey 1995).  
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5.8. POSTERIOR URETHRAL VALVES (PUV) 
 
Posterior urethral valves is the most common cause of obstructive uropathy involving the 
lower urinary tract in childhood (Smith and Duckett 1996). The anomaly occurs only in 
males, with the incidence of PUV estimated at 1 in 4000-8000 boys (Atwell 1983, Hutton 
et al. 1994). PUV has been suggested to consist of a thin congenital membrane that 
impedes urine outflow by obstructing or partially obstructing the posterior urethra (Smith 
and Duckett 1996). The exact etiology of PUV is, however, unclear. PUV is usually a 
sporadic disorder. There are, however, reports of PUV in siblings and twins, suggesting a 
partial genetic etiology (Thomalla et al. 1989, Hutton and Thomas 1994, Trembath and 
Rijhsinghani 2002).  
 
Young and coworkers classified valves as type I, II, or III. Much of their orginal 
classification has, however, been questioned (Smith and Duckett 1996). At present, in most 
cases, the diagnosis of PUV is made before or at birth when a boy is evaluated for 
antenatal hydronephrosis. However, the sensitivity of US in detecting PUV is under 50%, 
and thus normal US, especially when performed early in gestation (before the 24th 
gestational week), does not exclude PUV (Helin and Persson 1986, Dinneen et al. 1993, 
Hutton et al. 1994). Before the use of antenatal US, PUV was usually detected during 
evaluation of UTI, weak urinary stream, abdominal mass, poor weight gain, or renal 
failure.  
 
In cases with suspicion of PUV, urinary tract US should be performed as soon as possible. 
The diagnosis is confirmed by using VCUG, which is the gold standard and method of 
choice for diagnosing PUV. If the patient has a normal VCUG, then PUV is excluded. 
From the VCUG study, the presence of VUR can also be concurrently evaluated. A renal 
isotope scan (MAG-3, DMSA and/or DTPA) is helpful in many cases, giving information 
about the presence of renal scarring or dysplasia or secondary ureterovesical junction 
(UVJ) obstruction from bladder hypertrophy (Smith and Duckett 1996). Urodynamic 
evaluation should be performed in all PUV patients throughout childhood because bladder 
compliance may deteriorate over time (Kim et al. 1997, Glassberg 2001). Cystoscopy is 
useful both in confirming diagnosis and in treatment. To follow the renal function of 
patients with PUV, regular measurement of serum creatinine or cystatin C is mandatory 
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(Ylinen et al. 1999). If serum creatinine or cystatin C values are higher than normal, the 
more accurate measurement of GFR is recommended by e.g. using plasma clearance of 
51chromium-ethylenediamine tetra-acetic acid (51Cr-EDTA). The Schwartz formula can be 
used for the calculation of GFR as well (Smith and Duckett 1996).  
 
Controversy exists about the best timing and approach in treating patients with PUV. 
Surgical treatment may comprise primary transurethral endoscopic valve ablation alone, 
primary valve ablation with upper urinary tract diversion (ureterocutaneostomy or 
pyelostomy), or temporary vesicostomy with delayed valve ablation. Many pediatric 
urologists advocate primary valve ablation, reserving urinary diversion for patients who do 
not rapidly respond to therapy (Mitchell and Close 1996, Smith et al. 1996, Close et al. 
1997, Duckett 1997). The main argument against urinary tract diversion is that a temporary 
defunctionalization of the bladder has an iatrogenic and deleterious effect on its later 
function. However, some authors favor high diversion, suggesting that it can improve renal 
function by preserving renal parenchyma and has no adverse effect on subsequent bladder 
function (Lyon et al. 1992, Jayanthi et al. 1995, Kim et al. 1996).  
 
Patients with PUV present with a broad spectrum of clinical severity, with sequelae 
ranging from voiding dysfunction without renal impairment to early onset of renal failure 
and occasionally even death. During recent years the prognosis of PUV patients has 
improved significantly. Mortality has decreased from 50% to less than 5% in the last 30-40 
years (Williams et al. 1973, Agarwal 1999). PUV is still, however, the most common 
obstructive condition causing chronic renal failure (CRF) and ESRD in children (Smith 
and Duckett 1996). The reported frequency of ESRD in patients with PUV varies from 9% 
to 47% (Warshaw et al. 1985, Parkhouse et al. 1988, Connor and Burbige 1990, Reinberg 
et al. 1992, Smith et al. 1996, Lal et al. 1999). The frequency of ESRD is strongly 
influenced by the length of the follow-up. ESRD is typically seen in two distinct age 
groups; in one-third of cases, ESRD develops soon after birth, and in the remaining two-
thirds renal function does not deteriorate until adolescence (Smith and Duckett 1996). 
Late-onset renal failure was previously thought to be caused by the increased metabolic 
demands of puberty. Current theories include hyperfiltration, reflux nephropathy, and 
persistent abnormal bladder function (Karmarkar 2001). In addition to the development of 
treatment methods, the invention of antenatal US has been proposed to improve the 
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outcome of patients with PUV (Cendron et al. 1996). However, in studies where the 
outcome of antenatally detected PUV patients was compared with that of postnatally 
detected patients, no proof of better outcome in the former group was observed (Reinberg 
et al. 1992, El-Ghoneimi et al. 1999).  
 
Factors claimed to be associated with a poor long-term outcome in patients with PUV 
include antenatal detection or presentation before the age of one year; late diagnosis; 
bilateral, especially dilating, VUR; injury of the detrusor muscle caused by outlet 
obstruction; bilateral absence of corticomedullary junction in US; recurrent UTIs; delayed 
achievement of urinary continence, and persistent elevation of serum creatinine after valve 
ablation (Tejani et al. 1986, Parkhouse et al. 1988, Hulbert et al. 1992, Denes et al. 1997, 
Hutton et al. 1997). On the other hand, unilateral, especially left-sided, VUR and renal 
dysplasia, or PUV associated with urinary ascites and perirenal urinoma or large 
congenital type bladder diverticula have been proposed to provide a “pop-off mechanism”, 
resulting in preservation of renal function (Hoover and Duckett 1982, Rittenberg et al. 
1988). In a recent study by Cuckow et al. (1997), however, persistent unilateral VUR with 
ipsilateral renal nonfunction and renal dysplasia did not seem to have a protective effect on 
contralateral renal function.  
 
Renal dysplasia has been observed to be present in many of the patients with PUV (Cussen 
1971, Johnston 1979, Henneberry and Stephens 1980, Hoover and Duckett 1982, Haecker 
et al. 2002). Although the association of PUV with renal dysplasia is well-recognized, the 
cause-and-effect relationship is poorly understood. Renal dysplasia has been proposed to 
be a primary developmental malformation of the ureteric bud (Henneberry and Stephens 
1980). Alternatively, dysplasia has been speculated to be caused secondarily by high 
intraluminar pressure during differentiation of the metanephric blastema (Beck 1971). 
After birth, the renal parenchyma can be damaged further by VUR and recurrent UTIs. 
This damage should, however, be at least partly preventable by intensive postnatal therapy.  
 
Urinary incontinence is a common problem in boys with PUV. The prevalence of 
incontinence has been reported to be as high as 81% at the age of 5 years and 54% at the 
age of 10 years (Churchill et al. 1983, 1990, Parkhouse et al. 1988, Connor and Burbige 
1990, Smith et al. 1996). In most cases, incontinence is speculated to be due to abnormal 
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bladder function combined with high urine output as a result of poor concentration ability 
(Smith et al. 1996). The reported incidence of symptomatic voiding dysfunction after 
surgery ranges from 13% to 38% (Krueger et al. 1980, Churchill et al. 1983, Scott 1985, 
Peters and Bauer 1990). Urodynamic abnormalities remain present in 20% to 88% of PUV 
patients despite adequate relief of urethral obstruction (Bauer et al. 1979, Koff 1983, 
Parkhouse and Woodhouse 1990, Peters et al. 1990, Lopez Pereira et al. 2002).  
 
The function of the bladder has been found to be related to the outcome of patients with 
PUV. In the early 1980s, Mitchell presented the concept of “valve bladder syndrome” for 
patients with a thick-walled, poorly compliant bladder with high resting pressures even at 
small urine volume, resulting in progressive hydroureteronephrosis and renal failure 
(Mitchell 1982). Later reports have also emphasized the association between voiding 
dysfunction and persistent hydroureteronephrosis and VUR, late-onset renal failure, and 
poor allograft survival in valve transplant patients (Parkhouse et al. 1988, Reinberg et al. 
1988). The surgical treatment method chosen has also been claimed to be related to the 
development of bladder dysfunction. In 1997, Duckett concluded that the valve bladder 
was an iatrogenic phenomenon that was the consequence of supravesical diversion and not 
secondary to either vesicostomy or primary valve ablation. In contrast, many other studies 
have observed that supravesical urinary diversion has no adverse effect on bladder function 
(Jayanthi et al. 1995, Kim et al. 1996, Jaureguizar et al. 2000, Liard et al. 2000, Podesta et 
al. 2000). Jaureguizar et al. (2000) postulated that poor bladder function is probably a 
consequence of detrusor damage in utero and has little to do with the mode of primary 
treatment. 
 
Reports concerning the outcome of renal transplantation in children with PUV have been 
contradictory. Some earlier studies have indicated that children with renal failure 
secondary to PUV show a trend towards decreased renal graft survival or function 
compared with children with ESRD secondary to nonobstructive etiology (Churchill et al. 
1988, Reinberg et al. 1988). In these studies, authors postulate that persistent bladder 
dysfunction is the basis of decreased graft function. Recent studies have, however, reported 
no decrease in graft survival in these patients as compared with controls (Connolly et al. 
1995, Salomon et al. 1997, Indudhara et al. 1998). 
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Impaired sexual function and reduced fertility may occur in patients with PUV. These can 
be caused by several factors, including cryptorchidism, vasal reflux, ejaculatory 
dysfunction, decreased libido and potency due to CRF, and damage to the erectal nerves of 
the penis (Woodhouse et al. 1989, Woodhouse 1994, Nguyen and Peters 1999, Karmarkar 
2001). 
 
 
5.9. OTHER ANTENATALLY DETECTABLE URINARY TRACT ANOMALIES 
 
5.9.1. Megaureter 
 
A megaureter is a term used to anatomically describe the wide ureter. According to the 
international classification scheme, a megaureter may be obstructed, refluxing, or 
unobstructed and not refluxing (Noe 1996). Each of these groups can be divided into two 
subgroups: primary megaureter, where the cause of dilatation is idiopathic, and secondary 
megaureter, which may be caused by urethral obstruction, bladder outlet obstruction, 
neurogenic bladder, polyuria, or infection (Shokeir and Nijman 2000). Primary megaureter 
is the second to third most common cause of hydronephrosis detected during the antenatal 
period and is also a common cause of hydronephrosis among young children (Brown et al. 
1987, Meyer and Lebowitz 1992, Ring et al. 1993, Ebel 1998, James et al. 1998). Males 
are four times more frequently affected than females. Megaureter is bilateral in about 25% 
of cases. In unilateral cases, the left ureter is involved 1.6-4.5 times more often than the 
right (Shokeir and Nijman 2000). Currently, about half of the cases are asymptomatic and 
discovered in antenatal US (Shokeir and Nijman 2000). Spontaneous resolution of 
megaureter is common, and conservative management is recommended at least in cases 
where renal function and hydronephrosis remain stable or improve and the child remains 
asymptomatic (Keating et al. 1989, Baskin et al. 1994, Liu et al. 1994, Arena et al. 1998, 
Vereecken and Proesmans 1999). Antibiotic prophylaxis is advised, especially in refluxing 
megaureters (Baskin et al. 1994). If surgery is required, ureteric excisional tapering is 
preferred for severely dilated ureters and plication of the distal ureter for less dilated units 
(Shokeir and Nijman 2000). 
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5.9.2. Renal duplication 
 
A duplex or duplicated system, defined as a renal unit in which the kidney has two 
pelvicalyceal systems, is associated with either a single ureter, bifid ureters (in which two 
ureters join before emptying into the bladder), or two ureters (Snyder 1996). In patients 
with complete duplication, two ureters are present that empty separately into the bladder, 
whereas in patients with partial or incomplete duplication, either a single or bifid ureter is 
present. In clinical practice, duplication anomalies are observed about two times more 
commonly in girls than in boys (Decter 1997). Ureteral duplication has been reported to 
occur bilaterally in up to 40% of cases. The right and left sides seem to be equally affected 
(Snyder 1996). There is a genetic predisposition to duplication; duplication of the ureter 
has a birth frequency of about 1%, and the proportion of siblings and parents of probands 
affected is about 12% (Carter 1984).  
 
Patients with complete duplication of ureters commonly have VUR in the lower pole 
orifice (Decter 1997). VUR in duplex kidneys was previously thought to be an indication 
for early surgical management by using ureteral reimplantation. In recent years, however, 
several studies have reported that low-grade VUR (grades I to II) in a lower pole ureter has 
a good spontaneous resolution rate, and conservative follow-up with antibiotic prophylaxis 
as a primary treatment is therefore recommended (Ben-Ami et al. 1989, Lee et al. 1991). 
High-grade VUR (grades III to V) with severe associated nephropathy is usually managed 
by excision of the affected lower pole and partial or total ureterectomy of its ureter (Decter 
1997).  
 
In some cases with ureteral duplication, the upper pole ureter is ectopic. Ectopic ureters 
clinically present more frequently in girls than in boys, and of all ectopic ureters, 70% to 
90% are associated with duplex kidneys (Chowdhary et al. 2001, Berrocal et al. 2002). The 
function of the upper pole in cases with ectopic orifice is often quite poor. In these 
patients, the upper pole is removed by an upper pole heminephrectomy, and the distal end 
of the upper pole ureter is treated in the same fashion (Decter 1997). In cases with 
favorable renal function, either a procedure that preserves the upper pole or merely 
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conservative follow-up is recommended (Jee et al. 1993b, El-Ghoneimi et al. 1996b, 
Shankar et al. 2001).  
 
Increasing numbers of duplex systems are diagnosed antenatally by US, many of the 
patients being asymptomatic at least in short-term follow-up. The identification of 
duplication prior to the onset of complications, such as UTI, has been proposed to improve 
the outcome of these patients. Van Salvage and Mesrobien (1995) concluded that early 
recognition and treatment of duplication anomalies with hydronephrosis are efficient in 
preventing considerable postnatal morbidity. They found that three times as many 
hydronephrotic upper pole moieties were functional and could thus be preserved in the 
group with antenatally detected hydronephrosis as compared with patients who presented 
postnatally. However, in the retrospective study of Hulbert and Rabinowitz (1998), 
antenatal diagnosis of significant duplex system hydronephrosis did not improve the rate of 
segmental salvage when compared with patients who presented with symptoms at an older 
age. 
 
 
5.9.3. Ureterocele 
 
A ureterocele is a cystic dilatation of the intravesical submucosal portion of the ureter 
(Snyder 1996). A ureterocele may subtend a single system or, more commonly, the upper 
pole ureter of a duplex system. Ureteroceles appear 3 to 4 times more often in girls than in 
boys. The left side is affected more frequently than the right side, with bilaterality being 
present in approximately 10% of cases (Decter 1997). Due to the advent of routine 
obstetric US examination, the number of patients with an asymptomatic ureterocele has 
increased. Antenatal diagnosis of a ureterocele has been reported to decrease morbidity 
and potential adverse outcomes related to infection, and is associated with a decreased rate 
of secondary procedures (Upadhyay et al. 2002). The best approach of managing these 
patients is, however, controversial, different managing strategies including primary 
endoscopic incision, upper pole heminephrectomy with or without lower tract 
reconstruction, conservative management, and total nephroureterectomy (Shokeir and 
Nijman 2002).  
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5.9.4. Ectopic ureter 
 
An ectopic ureter is characterized by an ectopic ureteric orifice outside the bladder trigone. 
An ectopic ureter can drain a single kidney, however, about 70% to 90% are associated 
with complete ureteral duplication (Chowdhary et al. 2001, Berrocal et al. 2002). 
Approximately one-half of female patients with ectopic ureters present with a classic 
history of continuous dribbling incontinence, but in some cases ectopic ureters can already 
be observed in utero due to concomitant hydronephrosis. Boys typically present with 
infectious complications (Chowdhary et al. 2001). The most frequent anomaly associated 
with an ectopic ureter is hypoplasia or dysplasia of the renal moiety (Borer et al. 1998, 
Wakhlu et al. 1998, Berrocal et al. 2002).  
 
 
5.9.5. Renal agenesis 
 
Renal agenesis is a relatively common congenital urinary anomaly that is typically 
diagnosed during antenatal US examination. Renal agenesis is usually unilateral but can be 
bilateral. Since bilateral renal agenesis is incompatible with life, its clinical significance is 
limited. Unilateral renal agenesis may be an isolated anomaly or may be associated with 
chromosomal abnormalities or a variety of nonchromosomal syndromes (Koff and Wise 
1996). Most commonly, it is associated with genital anomalies, which are more frequent in 
females than in males. The frequency of unilateral renal agenesis is, however, slightly 
higher in males (Koff and Wise 1996). Of the abnormalities in the contralateral kidney, 
VUR predominates (Song et al. 1995, Cascio et al. 1999). The outcome of patients with 
unilateral renal agenesis is generally good, and they have normal longevity. However, life-
long follow-up of these patients is indicated due to their increased risk of developing 
proteinuria, hypertension, and renal insufficiency (Koff and Wise 1996). 
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5.9.6. Prune Belly syndrome 
 
Prune Belly syndrome can also be the cause of antenatally detected hydronephrosis. The 
syndrome is a specific constellation of anomalies consisting of an abdominal wall deficient 
in muscular tissue, bilateral undescended testes, and an abnormal urinary tract 
characterized by tortuous dilated ureters, megalocystis, dilated prostatic urethra, and renal 
dysmorphism (Coplen et al. 1996). The abdominal wall is lax, distended, and wrinkled. In 
many cases, patients also have other associated anomalies such as cardiopulmonary, 
gastrointestinal, and musculoskeletal abnormalities (Jennings 2000).  
 
 
5.9.7. Megacystis-megaureter syndrome 
 
The term megacystis-megaureter designates a finding of hydroureteronephrosis, a large, 
thin-walled bladder, and high-grade VUR. Routine obstetric US examination has increased 
the incidence of this syndrome, which can be predicted with reasonable accuracy 
antenatally (Willi and Lebowitz 1979, Mandell et al. 1992).  
 
 
5.9.8. Transitional urinary tract dilatation 
 
In many cases, urinary tract dilatation detected during the antenatal period resolves either 
before the end of pregnancy or within the first year of life. This transitional urinary tract 
dilatation has been suggested to be due to high fetal urine production, insufficient 
maturation of the PUJ or UVJ, or reflux of urine from the bladder to the kidney 
(Woodward and Frank 2002). The reported frequency of transitional hydronephrosis in 
patients with antenatal urinary tract dilatation has varied from 15% to 75% (Corteville et 
al. 1991, Blyth et al. 1993, Lam et al. 1993, Gunn et al. 1995, Sairam et al. 2001, 
Woodward and Frank 2002).  
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6. AIMS OF THE STUDY 
_________________________________________________________________________ 
 
The main objective of this study was to clarify the long-term outcome of antenatally 
detected urinary tract anomalies and to investigate whether the outcome of patients with an 
antenatally detected urinary tract anomaly differs from that of patients with a postnatally 
detected condition. 
 
Specific aims of the study were: 
 
1. to examine the demographic features and renal outcome of fetal VUR (I); 
 
2. to evaluate criteria for a conservative versus a surgical approach in the treatment of 
MDK and to determine optimal timing of surgery, when indicated (II); 
 
3. to investigate the significance of different prognostic factors and the long-term renal 
outcome in boys with PUV detected either antenatally or during infancy (III); 
 
4. to clarify the long-term outcome of patients with antenatally detected PUJ obstruction 
treated either conservatively or operatively (IV). 
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7. PATIENTS AND METHODS 
_________________________________________________________________________ 
7.1. PATIENTS  
 
The study groups are shown in Table 1. Patient collection was based on the hospital patient 
registry. 
 
Table 1. Patient data in Studies I-IV.  
_________________________________________________________________________ 
Study Diagnosis  Number of patients Mean follow-up,  
   (antenatal/postnatal) years (range) 
_________________________________________________________________________ 
I VUR  51 (21/30)  7.4 (2.7-19.5) 
 
II MDK  48 (37/11)  3.8 (2.0-10.5) 
 
III PUV  46 (23/23)  12.5 (5.5-20.1) 
 
IV PUJ obstruction 68 (68/0)  7.9 (3.7-19.6) 
_________________________________________________________________________ 
VUR=vesicoureteral reflux, MDK=multicystic kidney, PUV=posterior urethral valves,  
PUJ=pelviureteric junction 
 
 
Study I: The sample included patients born between 1983 and 1999 with either 
hydronephrosis detected antenatally by using obstetric US and confirmed postnatally to be 
due to VUR or VUR diagnosed after developing the first UTI during the neonatal period 
(before the age of 28 days). All patients were treated at the Hospital for Children and 
Adolescents, University of Helsinki. There were 21 antenatally detected and 30 neonatally 
detected patients, having 35 and 51 refluxing units, respectively. All patients were 
considered to represent cases of fetal VUR. Routine US examination had been performed 
during pregnancy on all mothers, including mothers of neonatally detected cases, with the 
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first examination occurring close to the 20th gestational week. In all neonatally detected 
cases, the result of the antenatal US examination had been considered normal. The median 
gestational age at detection was 29 (range 14 to 40) weeks. The median age of the 
neonatally detected patients presenting with symptomatic UTI was 18 (range 3 to 27) days. 
Patients with VUR secondary to other urinary tract malformations or due to obstructive 
conditions of the lower urinary tract were excluded.  
 
Study II: The sample consisted of MDK cases born between 1989 and 1999 and treated at 
the Hospital for Children and Adolescents, University of Helsinki. There were altogether 
48 such cases. A routine US examination had been performed during pregnancy on all 
mothers, with the first examination occurring close to the 20th gestational week. Thirty-
seven of the cases (77%) were detected antenatally. The median gestational age at 
detection was 21 weeks. The median age at the time of diagnosis for the 11 postnatally 
detected cases was 6 days. There were 26 boys and 22 girls (M/F 1.2). All patients had 
unilateral MDK. The left kidney was affected in 28 cases, and the right kidney in 20 cases 
(L/R 1.4).  
 
Study III: The study population comprised 46 patients with PUV detected either 
antenatally (23 cases) or during infancy, i.e. within the first year of life (23 cases). The 
sample included all patients who were diagnosed and treated either at the Hospital for 
Children and Adolescents, University of Helsinki (42 cases), or at the Department of 
Pediatrics, Tampere University Hospital (4 cases), and who were born between 1983 and 
1997. Routine US had been performed during pregnancy on 40 of the 46 mothers (87%), 
with the first examination occurring close to the 20th gestational week. The median 
gestational age at detection was 28 (range 16 to 38) weeks. In the postnatally detected 
cases, the time of diagnosis ranged from one day to 356 days (median 31 days).  
 
Study IV: The sample included patients with antenatally detected hydronephrosis 
confirmed postnatally to be due to PUJ obstruction, and who were diagnosed and treated 
between 1983 and 1998 at the Hospital for Children and Adolescents, University of 
Helsinki. The first US had been performed on all mothers close to the 20th gestational 
week. In many cases, repeated US examinations were performed. The median gestational 
age at detection was 29 (range 15 to 38) weeks. The patients comprised 47 boys and 21 
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girls (M/F ratio 2.2). PUJ obstruction was unilateral in 54 patients and bilateral in 14 (82 
hydronephrotic units in total). In patients with unilateral PUJ obstruction, the left kidney 
was affected in 28 and the right in 26 cases (L/R 1.1). Patients with other urinary tract 
malformations were excluded.  
 
 
7.2. METHODS 
 
Antenatal and postnatal clinical records and all radiological and laboratory findings were 
analyzed retrospectively (I-IV). In the prospective part of the study, the patients with PUV 
were referred to outpatient visits, with the exception of 8 patients on dialysis or with 
kidney transplants, to define up-to-date status of their urinary tract and kidney function. 
Patients on dialysis or with kidney transplants already had up-to-date information on renal 
function. Of the 38 patients, 17 (45%) agreed to participate. At visits, urinary tract US, 
radionuclide scan (DMSA and/or DTPA), glomerular filtration rate (51Cr-EDTA), and 
urinary flow (plus US residual) were performed. Laboratory blood tests (hemoglobin, 
sodium, potassium, calcium, albumin, creatinine, cystatin C) were performed and urine 
samples (osmolality, sodium, potassium, creatinine, protein, albumin) obtained. In 
addition, blood pressure, weight, and height were measured. Anamnestic data with a 
special focus on UTIs, achievement of urinary continence, and method of treatment were 
also recorded. For the remaining 21 cases, the results of the last outpatient visit, where the 
status of urinary tract and kidney function had been thoroughly examined, were used to 
determine the long-term renal outcome and the end-point of follow-up of individual 
patients (III). 
 
 
7.2.1. Radiologic imaging studies  
 
All patients had initially undergone an US examination within the first week of life or 
during the first hospitalization. Ultrasonography was repeated every 3 to 6 months during 
the first year and every 12 to 24 months thereafter until either resolution of hydronephrosis 
(I, III, IV) or complete involution of MDK or nephrectomy (II). In cases with PUJ 
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obstruction, hydronephrosis was graded by using the Society of Fetal Urology grading 
system (Kletscher et al. 1991, Fernbach et al. 1993). 
 
Conventional radiopaque VCUG had been performed on all patients with hydronephrosis 
confirmed postnatally to be due to VUR and on all patients with PUV to confirm 
diagnosis. Furthermore, 43 of the 48 patients with MDK and 42 of the 68 patients with 
PUJ obstruction underwent a VCUG study to assess possible presence and grade of VUR. 
In refluxing cases, a follow-up isotope VCUG was performed every 6 to 24 months to 
evaluate the resolution of VUR. Reflux was graded according to the International 
Classification (Lebowitz et al. 1985). 
 
A DMSA scan had been performed on all patients with VUR, MDK, and PUV and on 20 
of the 68 patients with PUJ obstruction to detect parenchymal filling defects and split renal 
isotope uptake. Severely decreased function of a single renal unit was defined as a split 
isotope uptake of less than 30% in cases with VUR (I) or of less than 10% in cases with 
PUV (III). If detected at the first isotope scan and/or depicting global coexistent increased 
or heterogeneous echogenicity on US, the finding was considered to indicate congenital 
renal dysplasia. In patients with fetal VUR, isotope uptake defects were taken to indicate 
newly acquired renal scarring if observed at least 6 months after UTI (I). 
 
Split renal isotope uptake and excretion were estimated in all cases with PUJ obstruction 
by using a DTPA scan. The diuresis was enhanced by administration of furosemide and 
performed using a standard protocol (Tamminen et al. 1978, Vihma et al. 1983). The 
DTPA scan was performed initially at 5 to 6 weeks of age and repeated every 6 to 12 
months until the age of 2 years, and thereafter every 12 to 24 months if hydronephrosis had 
not resolved. In 3 cases with unilateral obstruction, MAG-3 was used alternatively in the 
initial examination.  
 
In most cases, intravenous urography (IVU) had been performed either initially or during 
follow-up to delineate the morphology of the upper tract more accurately. 
 
Urodynamic studies had been performed on all patients with PUV and also on patients for 
whom lower urinary tract dysfunction had been suspected.  
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7.2.2. Laboratory investigations 
 
Serum creatinine had been measured initially, at regular visits, and at the end of follow-up. 
In patients with PUV, creatinine was measured after urethral catheter drainage for at least 
3 days, after valve ablation, and thereafter during visits until the end of follow-up. GFR 
was measured using 51Cr-EDTA clearance or calculated from the Schwartz formula, height 
x K/ serum creatinine, where K=0.55 for patients aged 1 to 13 years and K=0.7 for those 
aged 13 to 21 years (Schwartz et al. 1987). In cases with PUV, GFR had been estimated at 
the end of follow-up using 51Cr-EDTA clearance in 40 cases and the Schwartz formula in 6 
cases (III). Urine cultures were obtained at regular visits and when UTI was suspected. 
Blood cultures were obtained if clinically indicated. C-reactive protein (CRP) was 
measured when PN was suspected.  
 
 
7.2.3. Blood pressure, weight, and height 
 
Blood pressure, weight, and height had been measured initially, during visits, and at the 
end of follow-up in most cases. Normal blood pressure was defined as systolic and 
diastolic pressure of less than the 95th percentile adjusted for age, sex, and height 
(Anonymous 1987b).  
 
 
7.2.4. Urinary continence 
 
The achievement of urinary continence in patients with PUV was recorded. Urinary 
continence was defined as being totally dry during both day and night.  
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7.2.5. Antimicrobial prophylaxis 
 
Low-dose antimicrobial prophylaxis using either trimethoprim or nitrofurantoin had been 
administered to all patients with VUR or PUV and to most patients with PUJ obstruction, 
initiated in antenatally detected cases within a few days of birth and in postnatal cases after 
detection of hydronephrosis. Prophylaxis had been continued in cases with VUR until 
spontaneous cessation or surgical treatment and in cases with PUV and PUJ obstruction for 
varying periods. 
 
 
7.2.6. Urinary tract infections 
 
Data concerning the first and recurrent and/or breakthrough UTIs were recorded. PN was 
defined as the combination of a positive urine culture (growth of ≥105 bacteria/ml in two 
sterile-bag specimens or any growth in a suprapubic bladder aspirate) in the presence of at 
least two of the following three criteria: pyuria (leukocyte count >10/mm3), fever ≥38.5°C, 
or a serum CRP level of ≥40 mg/l. Cystitis was defined as a combination of a positive 
urine culture (growth of ≥105 bacteria/ml in a sterile-bag specimen or any growth in a 
suprapubic bladder aspirate) and UTI signs and symptoms such as pyuria, low-grade fever, 
vomiting, and irritability.  
 
 
7.2.7. Indications and modes of treatment  
 
In cases with fetal VUR, indications for surgical treatment during follow-up were 
significantly decreased split isotope uptake, development of new scars, recurrent episodes 
of breakthrough UTIs, progressive dilating VUR (grade IV to V), and parents’ request. Ten 
of the 21 patients in the antenatal group (48%) and 14 of the 30 neonatal patients (47%) 
had eventually been treated surgically. Seventeen patients had undergone ureteral 
reimplantation, 2 had undergone unilateral nephrectomy, and 5 had been treated 
endoscopically. The mean age at the time of surgery was 13.1 (range 0.5 to 39.0) months.  
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All MDK patients had primarily been treated conservatively. The indication for 
nephrectomy had been an ultrasonographically still distinguishable tissue mass, whether 
increased, unchanged, or decreased in size, evaluated after at least 18 months of follow-up 
(median 25 months). Thirty-two of the 48 patients (67%) had eventually undergone 
nephrectomy. The mean age at surgery was 28 months. The multicystic mass had been 
removed in two cases at the ages of 11 and 12 months at the parents’ request. Furthermore, 
in two cases, the parents had refused recommended surgery. These two cases were 
excluded from statistical analysis.  
 
In PUV cases, the primary surgical treatment had consisted of valve ablation alone for 23 
patients. Temporary high diversion using a ”ring” ureterocutaneostomy had been 
performed in 19, unilateral pyelostomy in two, vesicostomy in one, and bilateral end-
cutaneostomies in one case. The mean age at the time of initial surgical intervention in 
antenatal cases was 19 (range 4 to 90) days and in postnatal cases 144 (range 4 to 365) 
days. 
 
In PUJ obstruction patients, 22 of the 54 unilateral cases (41%) had been treated 
conservatively until the end of follow-up, 20 (37%) had undergone early pyeloplasty, and 
11 (20%) late surgery. In addition, one patient had undergone early unilateral nephrectomy 
due to a nonfunctioning kidney. Of the 14 cases with bilateral obstruction, 9 (64%) had 
primarily been treated conservatively, one of which underwent late unilateral pyeloplasty. 
Five patients (36%) had undergone early surgery, four bilaterally and one on the worst side 
only. Operations had been performed due to either initially moderate or poor renal 
function, or deterioration in function during follow-up. Furthermore, in cases with good 
renal function, grade 4 hydronephrosis, grade 2 or 3 hydronephrosis with an obstructive 
washout pattern, persistently increasing dilatation during follow-up, PN, or recurrent 
abdominal pain had been indicative for surgery. The mean age for early surgery was 0.2 
(range 0.1 to 0.4) years, and for late pyeloplasty 2.0 (range 0.5 to 4.7) years.  
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7.2.8. Definition of long-term renal outcome in cases with PUV (III) 
 
In cases with PUV, long-term renal outcome was defined as favorable when renal function 
was either normal (GFR ≥90 ml/min/1.73m2) or moderately impaired (GFR from 60 to 
89ml/min/1.73m2), and poor when the patient had either CRF or ESRD (Heilbron et al. 
1991, National Kidney Foundation 2002). Chronic renal failure was defined as a stage 
where GFR was 59ml/min/1.73m2 or less (National Kidney Foundation 2002). End-stage 
renal disease was defined as a requirement for dialysis or renal transplantation.  
 
 
7.2.9. Definition of renal function in cases with PUJ obstruction (IV) 
 
Good, moderate, and poor renal function was defined as a split renal isotope uptake of 40% 
or more, of 30% to 39%, and of less than 30%, respectively. In cases with bilateral PUJ 
obstruction, split renal function served to determine the more affected side. If no difference 
in split uptake was present, GFR calculated by using the Schwartz formula was used to 
estimate whether the kidneys showed good (normal GFR) or decreased (GFR 
<89ml/min/1.73m2) function (Heilbron et al. 1991). 
 
 
7.2.10. Statistical analysis 
 
Values are expressed as means ± standard deviation (SD) unless otherwise reported. 
Analyses were conducted with SPSS software for Windows, Release 10.0.7 (SPSS, Inc., 
Chicago, IL, USA). Associations between categorical variables were examined by Fisher’s 
exact test. Differences between continuous variables were analyzed by using Student’s 
unpaired t-test. Student’s paired t-test was used to analyze changes within groups during 
follow-up (IV). The Kaplan-Meier method was used to identify the rate of development of 
ESRD (III). Spearman’s correlation was used to assess the relationship between the grade 
of hydronephrosis and the split renal isotope uptake in cases with unilateral PUJ 
obstruction (IV). Analysis of variance (ANOVA) was used to compare the mean value of 
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repeated measurements (II). All statistical tests were two-sided. A p-value of 0.05 or less 
was considered statistically significant.  
 
 
7.3. ETHICAL CONSIDERATIONS 
 
The use of patient information and the study protocols were approved by the Ethics 
Committees of the Hospital for Children and Adolescents, University of Helsinki, and of 
Tampere University Hospital. Written informed consent was obtained from the 17 patients 
and/or their guardians who chose to participate in the prospective part of the study after the 
design and purpose of the study had been explained.  
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8. RESULTS 
_________________________________________________________________________ 
8.1. DEMOGRAPHIC FEATURES OF PATIENTS WITH FETAL VUR (I) 
 
Males predominated among both antenatally and neonatally detected fetal VUR cases 
(Table 2). Bilateral dilating VUR was observed in 16 of the 30 neonatally detected cases 
(53%) versus in only 6 of the 21 antenatally detected cases (29%) (p=0.05). There was, 
however, no significant difference in the severity of VUR between the two groups when 
the side with the more severe grade of VUR was taken into account (p=0.16). Nor was any 
significant difference present in the frequency of bilateral VUR between males (24 of 36) 
and females (11 of 15) (p=0.24).  
 
Table 2. Demographic features of 51 patients with fetal VUR. 
_____________________________________________________________________ 
  Total Antenatal group Postnatal group 
  N (%)  N   (%)   N   (%) 
 51 (100) 21 (41)  30 (59) 
_____________________________________________________________________ 
Refluxing units 86 (100) 35 (41)  51 (59) 
Males  36 (71) 13 (62)  23 (77)  
Females  15 (29) 8 (38)  7 (23) 
  (M/F 2.4) (M/F 1.6)  (M/F 3.3)  
Unilateral VUR 16 (31) 7 (33)  9 (30)  
Bilateral VUR 35 (69) 14 (67)  21 (70) 
Grade of VUR  
I 0 (0) 0 (0)  0 (0) 
II 17 (20) 11 (31)  6 (12) 
III 30 (35) 11 (31)  19 (37)  
IV 27 (31) 7 (20)  20 (39)  
V 12 (14) 6 (17)  6 (12)  
____________________________________________________________________ 
VUR= vesicoureteral reflux 
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8.2. RECURRENT URINARY TRACT INFECTIONS (UTIs)(I, III) 
 
The frequency of recurrent and/or breakthrough UTIs in the different study groups is 
presented in Table 3. No significant difference was observed in the number of patients 
suffering from recurrent UTIs between antenatally and postnatally detected cases in any of 
the study groups (p>0.05).  
 
 
Table 3. Frequency of urinary tract infections in different study groups during follow-up. 
___________________________________________________________________________ 
VUR  MDK PUV PUJ  
   obstruction 
___________________________________________________________________________ 
No. of patients with recurrent 22 (43) 0 (0) 30 (65) 2 (3) 
and/or breakthrough UTIs (%) 
  Antenatal  8 (38) 0 (0) 14 (61) 2 (3) 
  Postnatal  14 (47) 0 (0) 16 (70) - 
 
No. of patients with recurrent 15 (29) 0 (0) 22 (48) 2 (3) 
and/or breakthrough PNs (%) 
  Antenatal 6 (29) 0 (0) 12 (52) 2 (3) 
  Postnatal 9 (30) 0 (0) 10 (43) - 
No. of PN episodes per   
patient  
  Antenatal 1.5 0 2.0 1.0 
  Postnatal 1.6 0 1.8 - 
___________________________________________________________________________ 
VUR=vesicoureteral reflux, MDK=multicystic kidney, PUV=posterior urethral 
valves, PUJ=pelviureteric junction, UTI=urinary tract infection, PN=pyelonephritis,  
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8.3. RENAL PARENCHYMAL DAMAGE (I, II, III) 
 
Of 51 cases with fetal VUR, renal scarring was observed in the DMSA scans in 9 renal 
units initially. In 5 of the 51 cases (10%), scars were indicative of congenital dysplasia 
(split isotope uptake of less than 30% and global increased/heterogeneous echogenicity in 
US); in 3 antenatal cases and in 2 neonatal cases (Table 4). Two additional antenatally 
detected male patients with bilateral grade 5 VUR showed bilateral renal increased global 
echogenicity on US. In 4 neonatally detected cases, scars were of focal appearance. By the 
end of follow-up, new defects, all of focal appearance, had been observed in 12 additional 
renal units (24%) in the neonatal group, whereas no units in the antenatal group had focal 
renal isotope defects, either initially or at the end of follow-up (p<0.005). All focal scars 
were associated with dilating VUR, while congenital renal dysplasia was associated with 
grade II to V VUR. The number of total and new focal scars was significantly higher in 
grades IV and V VUR than in grades II and III (p<0.05). The new focal scars were 
detected at a median age of 1.8 (range 0.5 to 4.6) years. Eleven of the 12 new scars were 
associated with one or more episodes of breakthrough PN.  
 
In all 48 cases with MDK, the multicystic conglomerate was nonfunctioning, with no 
isotope uptake (<5% of total function) in the initial DMSA scan. 
 
Thirteen of the 46 patients with PUV (28%) were observed to have congenital renal 
dysplasia (<10% of total function) in the initial renal isotope scan. At the end of follow-up, 
acquired progressive renal scarring was observed in 11 additional renal units. Renal 
damage was significantly associated with the presence of VUR; parenchymal damage was 
observed in 17 of the 47 refluxing units (36%) versus 7 of the 45 nonrefluxing units (16%) 
(p<0.05).  
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Table 4. DMSA isotope scan findings: A) split isotope uptake findings in 51 patients with 
fetal VUR, and B) focal renal scar findings in 86 renal units with fetal VUR. 
___________________________________________________________________________ 
A   Antenatal group Postnatal group 
 N   (%)   N   (%)                   _
Initially End of Initially End of  
    follow-up  follow-up 
___________________________________________________________________________ 
Normal split isotope uptake (≥44%) 16/21 (76) 16/21 (76) 25/30 (83) 24/30 (80) 
Mild decrease in split isotope 
uptake (30-44%)  2/21 (10) 2/21 (10) 3/30 (10) 4/30 (13) 
Overall split isotope uptake <30% 3/21 (14) 3/21 (14) 2/30 (7) 2/30 (7) 
___________________________________________________________________________ 
B   Antenatal group Postnatal group 
 N   (%)   N   (%)                            
_ 
Initially End of Initially End of  
    follow-up  follow-up 
___________________________________________________________________________ 
Focal scars/ renal units  0/35 (0) 0/35 (0) 4/51 (8) 16/51 (31) 
Grade I 0/0 (0) 0/0 (0) 0/0 (0) 0/0 (0) 
II 0/11 (0) 0/11 (0) 0/6 (0) 0/6 (0) 
III 0/11 (0) 0/11 (0) 1/19 (5) 4/19 (21) 
IV 0/7 (0) 0/7 (0) 3/20 (15) 10/20 (50) 
V 0/6 (0) 0/6 (0) 0/6 (0) 2/6 (33) 
___________________________________________________________________________ 
DMSA= renal scanning using 99mtechnetium-dimercaptosuccinic acid, VUR=vesicoureteral 
reflux 
 
 
8.4. RESOLUTION OF FETAL VUR DURING FOLLOW-UP (unpublished) 
 
Among the 27 patients with fetal VUR who were treated conservatively until the end of 
follow-up, a high and equally good resolution rate in grades II and III reflux (35 of 37 
renal units, 95%) was observed, whereas in grades IV and V, VUR ceased in only 7 of 13 
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renal units (54%) (p<0.005) (Table 5). However, even in grades IV and V VUR, a distinct 
tendency towards spontaneous improvement was observed during follow-up. Median age 
at cessation of VUR was 1.2 (range 0.3 to 6.4) years.  
 
 
Table 5. Outcome of VUR in 86 refluxing renal units of 51 patients with fetal VUR. 
___________________________________________________________________________ 
VUR  Total N of  Surgically Conservatively followed 
grade renal units treated
 ___________________________________________ 
   Total Resolved Improved Unchanged 
______________________N (%) N (%) N (%) N (%) N (%)_____ 
I -  - - - - 
 
II 17 3 (18) 14 (82) 12 (86) 1 (7) 1 (7) 
 
III 30 7 (23) 23 (77) 23 (100) - - 
 
IV 27 16 (59) 11 (41) 6 (55) 4 (36) 1 (9) 
 
V 12 10 (83) 2 (17) 1 (50) 1 (50) - 
___________________________________________________________________________ 
Total N (%) 86 36 (42) 50 (58) 42 (84) 6 (12) 2 (4) 
___________________________________________________________________________ 
VUR=vesicoureteral reflux 
 
 
8.5. OUTCOME OF MDK (II) 
 
Complete involution of the multicystic conglomerate was observed in US in 13 of the 48 
cases (27%). In 12 of these 13, involution occurred within 24 months and in one case at the 
age of 51 (median 14) months. Of the 32 cases to eventually undergo surgery, reduction in 
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the size of the cysts was observed in 19 (59%) and in 13 (41%) either no change (8) or a 
considerable increase (5) in the size of the conglomerate occurred during follow-up. 
Among the totally involuted cases, the size of the affected kidney was significantly smaller 
at birth than in nephrectomized cases (mean 4.6 cm vs. 5.9 cm; p=0.02) (Figure 1). The 
difference in size between involuted cases and those eventually undergoing surgery 
continued to increase during follow-up (repeat ANOVA; p<0.0001), the mean involution 
rate being 2.5 cm/year and 0.6 cm/year (between 0 and 18 months), respectively 
(p<0.0001). From 18 months onwards, no significant involution was observed in cases 
eventually subjected to nephrectomy (p>0.05).  
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Figure 1. Difference in the mean size (±SEM) of the multicystic conglomerate among 
conservatively followed patients and those subjected to nephrectomy. 
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8.6. LONG-TERM RENAL OUTCOME OF PATIENTS WITH PUV (III) 
 
Long-term renal outcome was poor in 14 (30%) of the 46 patients with PUV. Six of the 
boys (13%) developed CRF and 8 (17%) had ESRD (Figure 2). Six of the 8 patients with 
ESRD received transplants, and the other 2 cases are on dialysis (hemodialysis 1, 
peritoneal 1). Of the 32 patients classified as having a favorable long-term renal outcome, 
GFR was normal in 24 and moderately impaired in 8 at the end of follow-up. 
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Figure 2. Rate of development of end-stage renal disease (ESRD) in 46 boys with 
posterior urethral valves. 
 
 
8.7. PREDICTIVE FACTORS IN PATIENTS WITH PUV (III) 
 
Nine of the 14 boys (64%) with poor renal outcome had bilateral VUR as compared with 6 
of the 32 with favorable outcome (19%) (p<0.005). However, patients with unilateral VUR 
did not have significantly better outcome than those with bilateral VUR; 5 of the 17 boys 
(29%) with unilateral VUR vs. 9 of the 15 (60%) with bilateral VUR had poor renal 
outcome (p=0.07). Furthermore, no significant difference was present in long-term 
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outcome between patients with high-grade (III-V) and those with low-grade (I, II) VUR 
(p=0.08).  
 
Patients without breakthrough UTIs had a better outcome than those suffering from repeat 
UTI episodes (p<0.05). 
 
Nadir serum creatinine concentration during the first year of life was significantly lower in 
patients with a favorable outcome (mean 47±22 µmol/l) than in those ending poorly (mean 
136±77 µmol/l) (Table 6; p<0.001). Furthermore, the initial serum creatinine levels after 
valve ablation or 3 days after catheter treatment were significantly higher among boys with 
poor outcome than in cases with favorable outcome (p<0.005). 
 
Table 6. Creatinine values in 32 cases with favorable outcome and in 14 cases with poor 
long-term renal outcome. 
___________________________________________________________________________ 
  Cases with favorable outcome Cases with poor outcome 
___________________________________________________________________________ 
Initial serum creatinine value 
Mean ± SD 101 ± 79 µmol/l  226 ± 116 µmol/l 
Range  32-395 µmol/l  95-472 µmol/l 
 
Serum creatinine value after valve ablation 
Mean ± SD 47 ± 22 µmol/l  184 ± 131 µmol/l 
Range  29-126 µmol/l  43-523 µmol/l 
 
Nadir serum creatinine value  
Mean ± SD 47 ± 22 µmol/l  136 ± 77 µmol/l 
Range  30-126 µmol/l  43-253 µmol/l 
_________________________________________________________________________ 
 
Seventeen of the 46 boys (37%) achieved complete urinary continence by the age of 5 
years. Twenty-two of 27 (81%) with a follow-up period exceeding 10 years were 
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continent. The mean age at the time of attaining continence was 5.0 years. No association 
was found between early continence (<5 years) and long-term renal outcome (p=0.11).  
 
 
8.8. ROLE OF ANTENATAL DETECTION (I, III) 
 
In the group of patients with fetal VUR, the risk of acquired renal scarring was particularly 
high when dilating VUR was not detected until neonatally after the first UTI. Acquired 
focal renal scars developed during follow-up in 19% of renal units and were observed in 
neonatally detected cases only (p<0.005).  
 
Comparing patients with antenatally detected PUV with those with postnatally detected 
symptomatic PUV, no difference was found in the long-term renal outcome. Eight of the 
23 antenatally detected cases (35%) developed poor renal function (CRF 4, ESRD 4) as 
compared with 6 of the 23 detected postnatally (26%) (CRF 2, ESRD 4) (p=0.21). Neither 
was there any difference present in the mean age of advancing to ESRD between the two 
groups, 9.8 ± 9.1 years vs. 11.8 ± 3.6 years (p=0.81). VUR was present to a similar extent 
in the two groups; 8 antenatally detected and 9 postnatally detected cases had unilateral 
VUR, and 6 and 9 had bilateral VUR, respectively. Fourteen antenatal patients (61%) 
developed breakthrough UTIs compared with 17 postnatal patients (74%) (p=0.16). No 
difference was observed in the number of patients with either congenital primary or 
acquired dysplasia (6 antenatal and 7 postnatal patients) or acquired progressive renal 
scarring (6 antenatal and 5 postnatal renal units). Nor was any significant difference 
present in initial or nadir mean serum creatinine values between the antenatal and postnatal 
patients (p>0.05). Eleven antenatal and 6 postnatal patients had achieved urinary 
continence by the age of 5 years (p=0.08). The mean age at achieving continence was 4.1 
years among antenatally detected patients and 6.1 years among postnatal patients (p=0.17).  
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8.9. OUTCOME OF PATIENTS WITH UNILATERAL PUJ OBSTRUCTION (IV) 
 
Of the 22 patients treated conservatively, the grade of hydronephrosis increased during 
follow-up in 2, remained stable in 9, improved in 3, and resolved completely in 8 (Figure 
3a). Ipsilateral renal function remained good in all cases (Figure 3b). Mean split function 
was 51% both initially (range 43-67%) and at the end of follow-up (range 45-60%) 
(p=0.94).  
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Figure 3. a) Grade of hydronephrosis and b) split renal isotope uptake in 22 patients with 
unilateral pelviureteric junction obstruction treated conservatively. 
 
 
In 20 patients undergoing early pyeloplasty, hydronephrosis grade remained unchanged 
postoperatively in 2, improved in 17, and resolved completely in only one (Figure 4a). 
Renal function was initially good in 13 and remained unchanged after pyeloplasty (Figure 
4b). Renal function was moderate in 5 cases initially, improving from moderate to good in 
2, and remaining unchanged after surgery in 3. In 2 cases with initially poor function, no 
improvement occurred after pyeloplasty. In the entire early-operated group, the change in 
split renal function was insignificant after pyeloplasty (mean 43% vs. 45%, p=0.37).  
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Figure 4. a) Grade of hydronephrosis and b) split renal isotope uptake in 20 patients with 
unilateral pelviureteric junction obstruction who were operated on early. 
 
In 11 patients operated on later, hydronephrosis increased preoperatively in one and 
remained unchanged in the others. Postoperatively, hydronephrosis remained unchanged in 
4 cases and improved in 7 (Figure 5a). Renal function was primarily good in 9 patients 
(Figure 5b). During follow-up a decline from good to moderate occurred in 3 of the 9 
cases. However, moderate renal function improved to good in 2 of these 3 cases after 
pyeloplasty. In all 6 patients with good split isotope uptake at pyeloplasty, renal function 
remained stable during follow-up. In 2 cases with poor function initially, no improvement 
occurred either during the preoperative period or after late pyeloplasty. The mean split 
isotope uptake dropped from 48% initially to 42% before surgery (p<0.05). After surgery, 
the mean isotope uptake improved to 44%, representing no significant permanent loss of 
function (p=0.08).  
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Figure 5. a) Grade of hydronephrosis and b) split renal isotope uptake in 11 patients with 
unilateral pelviureteric junction obstruction who were operated on during follow-up. 
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The grade of hydronephrosis in patients with unilateral obstruction correlated poorly with 
split isotope uptake in the renal scan (r=-0.2, p=0.20; Figure 6).  
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Figure 6. Correlation between grade of hydronephrosis and split renal isotope uptake in 54 
patients with unilateral pelviureteric junction obstruction. Grade 1: 49.7 ± 4.1%; Grade 2: 
48.2 ± 7.1%; Grade 3: 44.3 ± 12.9%; Grade 4: 47.4 ± 16.3%. 
 
 
 
8.10. OUTCOME OF PATIENTS WITH BILATERAL PUJ OBSTRUCTION (IV) 
 
Among cases with bilateral obstruction treated conservatively, hydronephrosis remained 
unchanged in 13 units, improved in one, and resolved completely in 4. Among the surgical 
cases, hydronephrosis remained unchanged in 3 and improved in 6. In addition, one patient 
with good bilateral function underwent unilateral late pyeloplasty due to an increased 
hydronephrosis grade from 1 to 3. After the operation, hydronephrosis improved to grade 
2. In 8 patients treated conservatively until the end of follow-up, renal isotope uptake was 
bilaterally good initially as well as during and at the end of follow-up. In 3 of the 5 
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surgical patients, early renal function was good bilaterally both initially and after surgery, 
one of the patients undergoing pyeloplasty on one side only. In one patient with initially 
good function on one side and poor on the other, renal function improved after surgery. In 
one patient with bilaterally poor function, renal function recovered on one side and after 
temporary diversion remained poor on the other. Bilateral pyeloplasty at the age of 2.3 
years had no effect on renal function on either side. However, at the end of follow-up, the 
glomerular filtration rate of all patients was normal.  
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9. DISCUSSION 
_________________________________________________________________________ 
 
Antenatal US offers the opportunity for early recognition and treatment of congenital 
urinary tract anomalies and possible preservation of renal function. Theoretically, early 
recognition allows surgical treatment and/or antimicrobial prophylaxis to be initiated 
before any further damage or complications, e.g. urinary tract infection, occur. Antenatal 
US was thus initially enthusiastically proposed to be of particular benefit in cases with 
potential mortality, such as PUV. Over the years, however, the benefit of antenatal 
diagnosis has been questioned. Reports on the long-term renal outcome of antenatally 
detected urinary tract anomalies are limited. Furthermore, in only a few studies has the 
long-term renal outcome of patients with antenatally detected urinary tract anomaly been 
compared with that of postnatally diagnosed, usually symptomatic patients.  
 
 
9.1. OUTCOME OF PATIENTS WITH VUR DETECTED EITHER ANTENATALLY 
OR DURING THE NEONATAL PERIOD  
 
In our study, antenatal US examination had been interpreted as normal in all cases with 
neonatally detected symptomatic VUR despite many of the patients having bilateral 
dilating reflux. Moreover, in several earlier studies, the sensitivity of US in detecting VUR 
has been found to be poor (Zerin et al. 1993, Tibballs and De Bruyn 1996, Farhat et al. 
2000). In 4% to 28% of cases, antenatally detected hydronephrosis has been reported to be 
due to VUR (Najmaldin et al. 1990, Ring et al. 1993, Gunn et al. 1995, Anderson et al. 
1997, McIlroy et al. 2000, Brophy et al. 2002). Consequently, all antenatally detected 
hydronephrosis cases are today recommended to undergo a VCUG study after birth, 
especially when hydronephrosis has also been detected postnatally (Woodward and Frank 
2002, Phan et al. 2003). 
 
The reported renal outcome of patients with antenatally detected VUR is controversial. 
Some authors suggest the outcome to be distinctly worse than when VUR is detected later, 
in childhood (Anderson and Rickwood 1991, Assael et al. 1998, Polito et al. 2000a). 
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Others, by contrast, claim fetal VUR to be a relatively benign condition (Crabbe et al. 
1992, Yeung et al. 1997). With regard to demographic features, general agreement exists 
only on the marked preponderance of antenatally detected VUR in boys. Among our 
patients with fetal VUR, reflux was less common in boys (M/F 2.4) than reported generally 
(M/F 5 to 10), which may partly be explained by our exclusion of patients with other 
ureteral pathology. In earlier studies, patients with fetal VUR have been reported to present 
with bilateral and/or dilating VUR in about one-half of the cases (Gordon et al. 1990, Ring 
et al. 1993, Yeung et al. 1997, Assael et al. 1998, Herndon et al. 1999, McIlroy et al. 
2000). Interestingly, we found 53% of the patients with symptomatic disease detected 
neonatally to also have bilateral dilating VUR, whereas this was the case in only 29% of 
the antenatal group (p=0.05). However, the frequency distribution of the different grades 
among our antenatal group may more accurately reflect the true demography of fetal VUR. 
 
Renal scarring can result from either an acquired mechanism characterized by focal 
scarring due to UTI-associated VUR or congenital damage seen in patients with fetal VUR 
which is a significant element of dysplastic development. The etiology of the congenital 
renal damage observed in patients with fetal VUR is uncertain, but it has been postulated 
that sterile reflux during gestation can cause renal damage by interfering with normal renal 
development (metanephric differentiation) or that renal dysplasia and VUR are separate 
expressions of a malformed urinary tract, frequently coexisting but not necessarily causally 
related (Mackie and Stephens 1975). Congenital renal damage of varying severity, 
characterized by an overall decrease in split renal isotope uptake in the DMSA scan, has 
been reported to present in up to 30% to 40% of patients with fetal VUR. The criterium for 
decreased split isotope uptake has, however, varied from 25% to 45% in different studies. 
In addition, some of the previous subject pools have consisted of only patients with high-
grade VUR (Ring et al. 1993, Marra et al. 1994, Assael et al. 1998, Sweeney et al. 2001). 
Only 14% of our patients had severely damaged kidneys (split isotope uptake in the 
DMSA scan of less than 30% most probably attributable to congenital renal dysplasia), 
which is in accordance with other earlier reports (Farhat et al. 2000, Polito et al. 2000a).  
 
Infants with gross VUR and age <one year have been found to be at the greatest risk of 
further damage, particularly if PN occurs (Berg and Johansson 1983, Gleeson and Gordon 
1991, Martinell et al. 1995). Consequently, patients with VUR detected either antenatally 
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or during the neonatal period seem to be especially vulnerable to renal damage owing to 
their young age and VUR often being bilateral and of high grade. Theoretically, antenatal 
detection with antimicrobial prophylaxis initiated directly after birth prevents most UTIs. It 
is therefore commonly assumed that the early administration of antimicrobial prophylaxis 
prevents further renal scarring in VUR. Acquired scarring has, however, been reported to 
occur in 0% to 60% of kidneys in fetal VUR cases, regardless of adequate antimicrobial 
treatment (Winberg et al. 1974, Anderson and Rickwood 1991, Yu et al. 1997, McIlroy et 
al. 2000). Among our patients, acquired focal renal scars developed in 19% of renal units 
during follow-up, explicitly in dilating VUR and only in neonatally detected cases 
(p<0.005) despite the equal frequency of breakthrough UTIs in both groups. Our results 
suggest that proper prophylactic medication may protect the kidney from further damage 
when instituted before the development of UTI. The “first hit” caused by the primary 
pyelonephritic episode in neonatally detected patients may be the most important cause of 
renal scarring becoming evident during follow-up and may also render the kidney more 
susceptible to development of new focal scars. To prove the benefit of antimicrobial 
therapy in antenatally detected cases, prospective, randomized, and placebo-controlled 
trials are needed. These would, however, be unethical in a neonatal population.  
 
Because of the high spontaneous resolution rate of VUR, antimicrobial prophylaxis has 
been recommended as a primary mode of treatment in most studies. In our patients who 
were treated conservatively until the end of follow-up, the tendency for spontaneous 
resolution of grades II and III VUR was as high as 95%. The cessation rate of grades IV 
and V VUR was lower, 54%, in agreement with several reports (Yeung et al. 1997, Assael 
et al. 1998, Farhat et al. 2000). It should be noted, however, that 46% of our patients 
underwent surgical correction of VUR during follow-up for different indications. Thus, 
specifying the true percentages of spontaneous resolution of VUR was impossible.  
 
 
9.2. OUTCOME OF PATIENTS WITH MDK 
 
Historically, nephrectomy has been regarded as the treatment of choice in cases with 
MDK. At present, MDK is mostly treated conservatively by following patients with serial 
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US. During conservative follow-up, some multicystic conglomerates increase, some will 
remain unchanged, some decrease, and some involute completely. A significant number of 
MDKs have been reported to undergo spontaneous involution over time, the prevalence 
ranging from 10% at a mean of 33.5 months up to 75% at a mean of 16 months of 
observation (Vinocur et al. 1988, Orejas et al. 1992, Strife et al. 1993, Wacksman and 
Phipps 1993, Sukthankar and Watson 2000, Oliveira et al. 2001). When following MDK 
conservatively, many centers are content with a completely involuted MDK. It is, however, 
more complex if MDK persists in the US examination after an extended period of follow-
up. Some surgeons follow MDK conservatively regardless of whether the size of MDK 
increases, remains unchanged, or decreases. In part of the centres, however, nephrectomy 
is still an option in treating MDK, especially in the absence of involution (Sapin et al. 
1994, Webb et al. 1997, Kessler et al. 1998). We aimed at following MDK cases primarily 
expectantly and decided upon nephrectomy after a minimum follow-up period of 18 
months. During follow-up the indication for nephrectomy was an ultrasonographically 
distinguishable persisting tissue mass, whether increased, unchanged, or decreased in size. 
Consequently, 32 of the total of 48 patients (67%) were eventually subjected to surgery, 
the median age at nephrectomy being 25 months. Complete ultrasonographic involution 
occurred in 13 of the 48 cases (27%); the median involution time was 14 months. When 
comparing involuted cases with surgical cases, we observed distinct differences in the 
clinical behavior of the multicystic conglomerate. The size of the affected kidney in 
involuted cases was significantly smaller at the time of birth than in nephrectomized cases. 
Furthermore, over an 18-month follow-up, a consistent and significantly increasing 
difference was present in the involution rate between the completely involuted cases and 
those subjected to surgery. After 18 months of follow-up, no significant reduction was 
observed in the size of the conglomerate in the majority of cases eventually subjected to 
nephrectomy, the mean involution rate being in fact -0.01 cm/year between 18 and 24 
months (p>0.05). Based on these results, we recommend an age of about 2 years if the 
surgical route is chosen.  
 
When pondering the grounds for nephrectomy, the risk of late complications must be 
considered. Malignant change and hypertension are potential late complications of MDK 
(Homsy et al. 1997, Husmann 1998, Snodgrass 2000). Eighteen cases of renal malignancy 
associated with MDK have been reported so far, including 11 cases of Wilms’ tumor in 
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pediatric patients, with the remainder displaying mostly adult-type renal adenocarcinoma 
(Perez et al. 1998, Mingin et al. 2000). Because of the limited number of reported cases, 
the risk should not be overestimated. However, it should be noted that even in cases where 
US shows total involution of the multicystic conglomerate, some renal tissue may remain. 
This has been well documented in some earlier studies, where histological examination 
showed the presence of significant renal tissue with glomeruli, tubules, and multicystic 
pathology despite no residual renal or cystic tissue being observed in US (Pedicelli et al. 
1986, Gough et al. 1995). Nevertheless, in our opinion, it is logical to assume that the more 
dysplastic tissue present, the higher the risk of later malignant change.  
 
There have been 19 reported cases of hypertension associated with MDK (Husmann 1998, 
Snodgrass 2000, Oliveira et al. 2001). However, in only 7 of the 18 cases subjected to 
nephrectomy was hypertension resolved. The true prevalence of MDK-associated 
hypertension is as yet obscure, but indisputedly it is a rare occurrence. Furthermore, the 
true etiology of hypertension in cases with MDK is unclear, although in many of the 
previously reported cases, hypertension was concluded to be due to anomalies of the 
contralateral kidney (Husmann 1998). Pain and UTI have also been reported as late 
complications of MDK (Ambrose et al. 1982). The decribed cases, have, however, 
practically all been anecdotal. 
 
In treating patients with MDK, the economic and psychosocial consequences should also 
be considered. From the economic point of view, the costs of conservative treatment 
should be weighed against those of surgical removal of the multicystic conglomerate. If, 
for example, US is carried out 6 times during the first 2 years and thereafter annually for 8 
years to follow possible involution of the mass, or if US is performed every 3 months for 
3.5 years to exclude Wilms’ tumor, as has been proposed by Perez et al. (1998), the costs 
of both options at our institution exceed those of nephrectomy performed at 25 months of 
age. From a psychosocial point of view, the burden of prolonged follow-up on the family 
should be taken into account. According to the recommendations of the Multicystic Kidney 
Registry, the follow-up of patients with conservatively treated MDK should be life-long, 
including active follow-up with US every 3 to 6 months the first year, every 6 to 12 
months the next 5 years, and annually thereafter (Wacksman and Phipps 1993). The time 
and expense of repeated outpatient visits and ultrasonography examinations, and the 
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family’s concern and uncertainty about the child’s future health undoubtedly speak against 
an extended conservative follow-up. Moreover, the surgical treatment alternative of MDK 
is relatively safe and carries only a minimal risk of morbidity (Elder et al. 1995, Homsy et 
al. 1997). 
 
Regardless of whether MDK is treated conservatively or surgically, the overall outcome of 
these patients is favorable. The occurrence of late complications is rare. We observed one 
case of Wilms’ tumor in situ but no cases of hypertension or proteinuria. Furthermore, 
none of our patients suffered from breakthrough UTIs. One patient did experience 
abdominal pain on the ipsilateral side of the MDK, and a nephrectomy was performed due 
to pain and the unchanged size of the conglomerate. Because the ipsilateral kidney is 
nonfunctioning, the prognosis of patients with MDK depends on the contralateral kidney. 
Associated contralateral genitourinary anomalies are common, the prevalence rate varying 
from 22% to 53% (Greene et al. 1971, Sapin et al. 1994, Kessler et al. 1998, Perez et al. 
1998, Rudnik-Schöneborn et al. 1998). Renal function has been found to be slightly 
impaired in at least a portion of the patients with MDK, and therefore all patients with 
MDK are recommended to have long-term nephrourological follow-up (Rudnik-
Schöneborn et al. 1998, Kuwertz-Broeking et al. 2004). 
 
 
9.3. OUTCOME OF PATIENTS WITH ANTENATALLY DETECTED PUV 
 
The long-term renal outcome of patients with PUV was observed to be poor in 14 of the 46 
boys (30%) followed for a mean period of 12.5 years. Of the urinary tract anomalies, PUV 
is, however, one of the most common causes for CRF and ESRD (Smith and Duckett 
1996). In earlier studies, the frequency of patients having either CRF or ESRD at the end 
of follow-up has varied from 22% to 68% (Warshaw et al. 1985, Tejani et al. 1986, 
Reinberg et al. 1992, Jee et al. 1993a, Hutton et al. 1994, Smith et al. 1996, Lal et al. 1999, 
Lopez Pereira 2003). Still in only a few of the previous studies has the mean follow-up 
time exceeded 10 years (Tejani et al. 1986, Smith et al. 1996, Lal et al. 1999, Lopez 
Pereira et al. 2003). The length of the follow-up has an impact on the prevalence of a poor 
outcome, although in part of the cases with PUV, renal function does not deteriorate before 
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adolescence. In addition, the lack of a uniform definition of CRF in children has an impact 
on results. While CRF is generally defined as a permanent reduction of the GFR, the level 
of GFR below which patients are considered to have CRF ranges in different centers from 
9 to 80 ml/min/1.73m2 (Tejani et al. 1986, Parkhouse et al. 1988, Dinneen et al. 1993, 
Proesmans 1997, Wassner and Baum 1999, National Kidney Foundation 2002, Lopez 
Pereira et al. 2003). Moreover, in many of the earlier studies on the outcome of PUV 
patients serum creatinine value alone has been used to define CRF, the definition varying 
from a cut-off point of 106 µmol/l (1.2 mg/dl) to CRF being 2 SD higher than normal for 
age (Parkhouse et al. 1988, Reinberg et al. 1992, Dinneen et al. 1993, Hutton et al. 1997, 
Drozdz et al. 1998). In statistical analysis, the division of patients into only two outcome 
groups may oversimplify matters, especially if follow-up time of the patients inside a study 
group varies considerably, as those followed for a shorter period may still have a 
progressive course. In our study, 8 of the 32 patients classified with favorable long-term 
outcome had moderately impaired renal function at the end of the follow-up. Thus, at least 
some of these cases probably progress to ESRD, especially ones with a decreased GFR 
before adolescence.  
 
Different factors have been reported to have some prognostic value in the long-term 
outcome of individual PUV patients. Factors that have been associated with poor outcome 
in PUV cases are delayed diagnosis, bilateral VUR, poor detrusor function, delayed 
achievement of urinary continence, recurrent UTIs, and persistent elevation of serum 
creatinine concentration after valve ablation (Tejani et al. 1986, Parkhouse et al. 1988, 
Denes et al. 1997, Hutton et al. 1997). We observed poor long-term outcome to be 
significantly associated with the presence of bilateral VUR, breakthrough UTIs, and higher 
nadir serum creatinine values in the first year of life. However, no statistically significant 
association was found between long-term renal outcome and urinary continence or time of 
detection. According to different reports, the role of VUR in PUV is controversial. In some 
studies, neither bilateral nor unilateral VUR was observed to affect the clinical course of 
patients with valves (Reinberg et al. 1992, Smith et al. 1996). Consistent with our study, 
however, others have reported bilateral VUR to predict the eventual development of CRF 
and ESRD (Tejani et al. 1986, Parkhouse et al. 1988). The presence of VUR is known to 
predispose patients to PN. Here, also, cases with VUR suffered more breakthrough UTIs 
and PNs than patients without reflux. It thus follows that both of these features served as 
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prognostic factors of poor renal outcome in our study. The role played by early serum 
creatinine values in prognosis is well established, several earlier investigators emphasizing 
the prognostic importance of early serum creatinine levels in patients with PUV (Warshaw 
et al. 1985, Reinberg et al. 1992, Denes et al. 1997). The impact of urinary continence on 
the outcome of PUV patients is, however, more complicated. Delayed urinary continence 
has been reported almost without exception in cases with PUV. Postobstructive bladder 
dysfunction is postulated to be a principal factor in the etiology of incontinence in these 
patients. Persistent abnormal bladder function has also been speculated to explain, at least 
partly, the late onset of CRF typically seen in some of these cases. Parkhouse et al. (1988) 
reported early-achieved continence in cases with PUV to be associated with favorable 
outcome. Our study, by contrast, showed no significant association between early 
continence (<5 years) and favorable long-term outcome.  
 
In recent decades, the prognosis of patients with PUV has improved considerably. 
Antenatal detection was initially thought to improve the outcome of patients with PUV. In 
our study, we found no difference in long-term outcome between antenatally and 
postnatally detected PUV. To our knowledge, earlier studies have also failed to show that 
long-term outcome of boys with antenatally detected PUV is better than that of 
symptomatic boys with postnatally detected PUV. In fact, in one study, the outcome of 
patients antenatally detected was worse than the outcome of postnatally detected patients 
(Dinneen et al. 1993). One explanation for the above findings is that in the more 
obstructive, and thus, the more severe cases, hydronephrosis is more distinct already 
before birth, leading to the discovery of PUV in obstetric US examinations. Furthermore, 
of the postnatally diagnosed patients, the most obstructive cases probably are detected 
early in any case, whereas cases detected later are less obstructed, and therefore, more 
rarely end up with permanent CRF and ESRD.  
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9.4. OUTCOME OF PATIENTS WITH ANTENATALLY DETECTED PUJ 
OBSTRUCTION 
 
PUJ obstruction is the most common cause of antenatally detected hydronephrosis. The 
widespread use of antenatal US has contributed to an increase in awareness and detection 
the condition. The clinical severity of PUJ obstruction varies, however, considerably, and 
the challenge is to determine which cases are significantly obstructive and require surgery, 
as opposed to mere anatomical variants with no implication for renal function.  
 
At present, controversy exists about the optimal treatment for PUJ obstruction, and when 
surgical correction is required, about the optimal timing of pyeloplasty. Moreover, the 
available diagnostic methods are not capable of defining clinically significant obstruction 
in neonates. According to earlier studies, a change in split renal isotope uptake is probably 
the most valuable criterion in determining which hydronephrotic kidney will require and 
eventually benefit from pyeloplasty (Ulman et al. 2000). 
 
Forty-five of our 54 patients with unilateral PUJ obstruction had good renal function 
initially. In all except one case, renal function remained good irrespective of the treatment 
mode chosen. Undoubtedly, some cases with initially good renal function are at risk of 
renal deterioration during follow-up. Most of our early-operated patients probably did not 
actually require the surgery performed. The observation that unilateral PUJ obstruction 
with normal split isotope uptake is mostly a benign condition that rarely requires surgery is 
in accord with several earlier studies (Cartwright et al. 1992, Freedman and Rickwood 
1994, Ulman et al. 2000). 
 
Five of our patients showed moderate split function initially. In 3 other cases, renal 
function deteriorated from good to moderate prior to surgery. In 4 of these 8 cases, renal 
function improved to good after surgery. Two of these 4 underwent early surgery and 2 
were operated on later. Patients either with moderate renal function initially or with 
function deteriorating from good to moderate may benefit from surgery. In patients with 
moderate renal function initially, an improvement to good may, however, be due to normal 
renal maturation rather than to successful surgery. In cases of renal deterioration from 
good to moderate during follow-up, renal recovery has been observed by some authors to 
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occur in all cases after surgery (Koff and Campbell 1994, Palmer et al.1998, Ulman et al. 
2000, Chertin et al. 2002), whereas others have reported the loss of renal function to be 
irreversible (Cornford and Rickwood 1998, McAleer and Kaplan 1999, Subramaniam et al. 
1999). 
 
Of our 4 patients with poor renal function at diagnosis, 2 were operated on early and 2 late. 
Surgery failed to improve renal function in all of them. In at least some cases, this may be 
due to irreversible renal damage sustained by the patients during the antenatal period. 
However, in some earlier studies, poor renal function has been observed to improve 
significantly after surgery or occasionally without any intervention (Koff and Campbell 
1994, Ulman et al. 2000).  
 
The hydronephrosis grade has been reported to correlate with split renal isotope uptake, 
and it has been suggested that both patients who need surgery and those who can be 
followed conservatively can reliably be identified by the grade of hydronephrosis, with 
grades 1 and 2 depicting clinically insignificant obstruction (Ulman et al. 2000, Konda et 
al. 2002). In our study group, however, split isotope uptake and hydronephrosis grade 
correlated poorly.  
 
A portion of the patients with bilateral PUJ obstruction can be treated conservatively but 
need to be closely followed up during the first years of life. In our material, there were 9 
patients with bilateral grade 1 to 3 hydronephrosis with equal split function. In following 
these cases, the GFR value according to the Schwartz formula was used to estimate 
whether bilateral renal function was good or had deteriorated. One patient underwent late 
unilateral pyeloplasty because the grade of hydronephrosis had increased. The remaining 
cases were followed conservatively; both hydronephrosis grade and renal function 
remained unchanged or improved.  
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9.5. FUTURE CONSIDERATIONS 
 
Reports concerning long-term outcome of patients with antenatally detected urinary tract 
anomalies remain limited, as routine obstetric US screening has only become more 
common since the 1980s. Now sufficient time has elapsed to study the long-term outcome 
of these patients and to compare the outcome of antenatally vs. postnatally detected cases 
to clarify the actual benefits of antenatal US screening.  
 
Increased knowledge of the long-term outcome of different urinary tract anomalies will 
allow patients and their guardians to be properly counselled, which may help to decrease 
anxiety. In addition, by elucidating the natural history and outcome of these anomalies, we 
may better direct investigations and treatment to those patients who actually need them. At 
present, because US screening has substantially increased the number of patients detected 
with asymptomatic urinary tract anomalies, many useless examinations are performed on 
patients who do not benefit from them, which increases the work load and the expenses to 
our healthcare system. Unnecessary examinations also increase the stress experienced by 
patients and their guardians. Furthermore, the best treatment for many anomalies is still 
controversial. Due to increased conservatism in treatment modes, the follow-up of patients 
has become significantly longer, with many asymptomatic patients suggested to need even 
life-long follow-up, forming a further drain on medical resources. 
 
Additional research is also needed to clarify the indications for and timing of postnatal 
examinations on patients with antenatally detected hydronephrosis to identify patients who 
would receive little/no benefit from further investigations and treatment, and to determine 
how long patients with different anomalies need to be followed, especially if treated 
conservatively. 
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10. CONCLUSIONS 
_________________________________________________________________________ 
 
The four original studies (I-IV) in this thesis evaluate the long-term renal outcome of 
patients with antenatally detected VUR, MDK, PUV, or PUJ obstruction.  
 
The main conclusions are: 
 
1. Renal injury occurs in an appreciable number of renal units with fetal VUR. The 
damage may be of congenital origin or may be acquired secondary to UTI.  
 
2. The risk of acquired renal scarring is particularly significant if dilating VUR is not 
detected until neonatally after the first UTI.  
 
3. Patients with antenatally or neonatally detected MDK can usually be followed 
conservatively. Involution by 18 months of age can be expected to occur in 
approximately one-fourth of cases. In the remaining cases, no significant involution 
usually occurs after 18 months. If surgery is be performed, the age of about 2 years 
is recommended.  
 
4. Poor long-term renal outcome among patients with PUV is associated with the 
presence of bilateral VUR. Nadir serum creatinine concentration during the first 
year of life is a valuable parameter for assessing long-term outcome. Delayed 
urinary continence is common but does not exert any significant effect on renal 
outcome.  
 
5. The outcome of patients with antenatally detected PUV does not differ from that of 
symptomatic postnatally detected patients. 
 
6. Unilateral PUJ obstruction with initially good isotope uptake is often a benign 
condition. Most of these cases can thus be followed conservatively. On rare 
occasions, however, split renal function will decrease, and pyeloplasty may become 
indicated. Some cases with moderately impaired renal function might benefit from 
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pyeloplasty performed either early or later. In patients with poor renal function, 
renal recovery may be minimal despite successful pyeloplasty for irreversible 
antenatal renal damage.  
 
7. Some of the patients with bilateral PUJ obstruction can be followed conservatively, 
but need to be closely followed up during the first years of life. In assessing renal 
function and indications for surgery, factors such as grade of hydronephrosis and 
GFR should be considered in addition to split isotope uptake.  
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